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ABSTRACT OF DISSERTATION 
 
 
 
 
ENANTIOSELECTIVE DEMETHYLATION: 
THE KEY TO THE NORNICOTINE ENANTIOMERIC 
COMPOSITION IN TOBACCO LEAF 
  
Nicotine and nornicotine are the two main alkaloids that accumulate in Nicotiana 
tabacum L. (tobacco), and nornicotine is the N-demethylation metabolite of nicotine. 
Nicotine is synthesized in the root, and probably primarily in the root tip.  Both nicotine 
and nornicotine exist as two isomers that differ from each other by the orientation of H 
atom at the C-2' position on the pyrrolidine ring. (S)-nicotine is the dominant form in 
tobacco leaf and the enantiomer fraction of nicotine (EFnic), the fraction of (R)-
enantiomer over the total nicotine, is approximately 0.002. Despite considerable efforts to 
elucidate nicotine and nornicotine related metabolism, a comprehensive understanding of 
the factors responsible for regulating the variable EF for nornicotine (0.04 to 0.75 ) 
relative to nicotine has been lacking. The objectives of these investigations were to 
understand the mechanisms behind the discrepancy. There are three nicotine 
demethylases reported to be active in tobacco. In vitro recombinant CYP82E4, 
CYP82E5v2 and CYP82E10 demethylated (R)-nicotine three, ten and ten-fold faster than 
(S)-nicotine, respectively, and no racemization was observed in either nicotine or 
nornicotine during demethylation. To confirm these in vitro results, the accumulation and 
demethylation of nicotine enantiomers throughout the growth cycle and curing process 
were investigated. Scion stock grafts were used to separate the contributions of roots 
(source) from leaves (sink) to the final accumulation of nicotine and nornicotine in leaf. 
The results indicate that nicotine consists of 4% of the R enantiomer (0.04 EFnic) when 
synthesized. However, (R)-nicotine is selectively demethylated by CYP82E4, CYP82E5 
and CYP82E10, resulting in an approximate 0.01 EFnic and 0.60 EFnnic  in the root. After 
most of (R)-nicotine is demethylated in root, nicotine and nornicotine are translocated to 
leaf, where nicotine is further demethylated. Depending on the CYP82E4 activity, an 
EFnnic of 0.04 to 0.60 is produced and only 0.2% of the remaining nicotine in the leaf is 
(R)-configuration. 
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Chapter 1. Literature review 
1.1. Tobacco pyridine alkaloids and derivatives 
Alkaloids are a group of basic substances which contain a cyclic nitrogenous nucleus. In 
Nicotiana plants most alkaloids are 3-pyridyl derivatives. Pyridine alkaloids in tobacco 
are listed in Figure S1.1. The genus Nicotiana, commonly referred to as tobacco plants, 
contains 3 subgenera, 14 sections and 66 species. The alkaloid composition has been 
reported by different independent investigations (Saitoh et al., 1985; Sisson and Severson, 
1990). Among the many alkaloids found in Nicotiana, nicotine is the principal alkaloid in 
commercial tobaccos. In leaves of 60 species of Nicotiana, nicotine is the predominant 
alkaloid in 33 species, nornicotine is the principal alkaloid in 24 species, anabasine is the 
principal alkaloid in 2 species, and anatabine is the principal alkaloid in 1 specie (Table 
1.1) (Saitoh et al., 1985). For the roots of 60 species of Nicotiana, Saitoh found 51 
species accumulated nicotine, 2 species accumulated nornicotine and 7 species 
accumulated anabasine.  
 
 
Table 1.1. Predominant alkaloid found in the Nicotiana species in greenhouse-grown 
plants (Saitoh et al., 1985). The two most abundant alkaloids are listed for each species. 
Results in parenthesis are from (Sisson and Severson, 1990). 
SUBGENUS 
Section 
   species 
Leaf Root 
 
SUBGENUS 
Section 
    species 
Leaf Root 
1
st
 2
rd
 1
st
 2
rd
 
 
1
st
 2
rd
 1
st
 2
rd
 
           RUSTICA 
     
PETUNIOIDES(cont‘d.)    
Paniculatae 
     
Noctiflorae     
glauca ab n ab n 
 
noctiflora nn(ab) n(nn) n ab 
paniculata n nn n nn 
 
petunioides (ab) (nn)   
knightiana n nn n nn 
 
acaulis (ab) (nn)   
solanifolia nn ab ab n 
 
ameghinoi     
benavidesii n ab ab n 
 
Acuminatae     
cordifolia n ab ab n 
 
acuminata n nn n nn 
raimondii n ab n ab 
 
pauciflora n nn n nn 
Thyrsiflorae 
     
attenuata n nn n nn 
thyrsiflora (nn) (n) 
   
longibracteata     
Rusticae 
     
miersii nn n n nn 
rustica n at n at 
 
corymbosa n nn n nn 
      linearis (n) (nn)   
TABACUM 
     
spegazzinii nn(n) at(nn) n at 
2 
 
SUBGENUS 
Section 
   species 
Leaf Root 
 
SUBGENUS 
Section 
    species 
Leaf Root 
1
st
 2
rd
 1
st
 2
rd
 
 
1
st
 2
rd
 1
st
 2
rd
 
Tomentosae 
 
 
   
Bigelovinae 
    tomentosa nn n(at) n nn 
 
bigelovii n nn(at) n nn 
tomentosiformis nn n(at) n at 
 
clevelandii n at n at 
otophora at(nn) nn(at) n nn 
 
Nudicaules 
    setchellii nn anab n nn 
 
nudicaulis nn at(ab) n nn 
gultinosa nn n n at 
 
Suaveolentes 
    kawakamii nn at(n) n nn 
 
benthamiana n ab n ab 
Genuinae 
     
umbratica n(nn) nn(n) n ab 
tabacum n nn(at) n at 
 
cavicola nn n n ab 
      debneyi ab n ab n 
PETUNIOIDES 
     
gossei n at n ab 
Undulatae 
     
amplexicaulis n at n at 
undulata n nn n nn 
 
maritima nn ab ab nn 
arentsii n ab n ab 
 
velutina nn ab n ab 
wigandioides n ab n ab 
 
hesperis n ab(nn) ab n 
Trigonophyllae 
     
occidentalis nn ab n ab 
trigonophylla nn at n nn 
 
simulans nn ab(n) n ab 
Alatae 
     
megalosiphon nn ab n ab 
sylvestris n nn n nn 
 
rotundifolia n ab n ab 
langsdorffii n at n at 
 
excelsior n at n ab 
alata n (ab) nn n 
 
suaveolens n nn n ab 
forgetiana n (nn) n at 
 
ingulba nn(n) ab(nn) n ab 
bonariensis n (nn) n nn 
 
exigua n nn n ab 
longiflora n(nn) (n) n nn 
 
goodspeedii nn ab n ab 
plumbaginifolia nn n n nn 
 
rosulata nn n n ab 
Repandae 
     
fragrans n at n at 
repanda nn ab n nn 
 
africana nn n nn n 
stocktonii n nn n at 
 
     
nesophila nn n n at 
     Note: n: nicotine; nn: nornicotine; ab: anabasine; at: anatabine 
 
 
 
Besides Nicotiana, nicotine has also been found in other species (Table 1.2). Edible 
Solanaceae plants (tomato, potato, eggplant and peppers) contain 15-240 ng g
-1
 dry 
weight nicotine (Davis et al., 1991; Siegmund et al., 1999). Based on average quantities 
Table 1.1 (continued) 
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of foods consumed, the daily intake of nicotine would be 1.4 µg (Siegmund et al., 1999), 
or 8.8 µg (Davis et al., 1991). 
 
 
Table 1.2. Plants, other than Nicotiana, in which nicotine has been reported (Davis et 
al., 1991; Leete, 1992). 
Scientific name Common name  Scientific name 
Common 
name 
Asclepias syriacus Milk weed  Erythroxylum coca Coca 
Acacia concinna Acacia  Lycopersicon 
esculentum 
Tomato 
Atropa belladonna Deadly 
nightshade 
 Lycopodium clavatum Club moss 
Cannabis sativa Marijuana  Mucuna Velvet-ban 
Carica papaya Papaya  Petunia violacea Petunia 
Capsicum annuum  Green peppers  Sedum acre Mossy 
stonecrop 
Datura stramonium Jimson weed  Sempervivum 
arachnoideum 
Hens and 
chicks 
Duboisia hopwoodii Pituri  Solanum melagena Egg-plant 
Duboisia 
myoporoides 
Corkwood  Solanum tuberosum Potato 
Equisetum palustre Horsetail  Zinnia elegans Garden zinnia 
 
 
1.2. Biosynthesis of the four main alkaloids in tobacco 
1.2.1. Pyridine, pyrrolidine and piperidine ring formation 
The pyridine ring is synthesized from nicotinic acid or its derivatives. Nicotinic acid is an 
intermediate of the nicotinamide adenine dinucleotide (NAD) pathway (Katoh and 
Hashimoto, 2004). In nicotinic acid biosynthesis, aspartate is oxidized by aspartate 
oxidase (AO) to form α–iminosuccinic acid (Figure 1.1). Then α-iminosuccinic acid is 
condensed and cyclized with glyceraldehyde-3-phosphate (GAP) by quinolinic acid 
4 
 
synthase (QS), yielding quinolinic acid. Finally nicotinic acid with its pyridine ring is 
formed from quinolinic acid in the NAD cyclic steps. 
 
The pyrrolidine ring is derived mostly from ornithine and possibly some from arginine 
via the symmetric diamine putrescine (Leete, 1992). First, ornithine is converted to 
putrescine by ornithine decarboxylase (ODC). Additionally, arginine is converted to 
putrescine, via agmatine and N-carbamoylputrescine, with argine decarboxylase (ADC) 
and agmatine deiminase (AIH). Next, putrescine is converted to N-methylputrescine 
through S-adenosylmethionine-dependent N-methylation catalyzed by putrescine N-
methyltransferase (PMT), which is the first committed step in the formation of 
pyrrolidine. N-methylputrescine is oxidatively deaminated by N-methylputrescine 
oxidase (MPO) to 4-methylaminobutanal, which spontaneously cyclizes to N-methyl-Δ
1
-
pyrrolinium cation. 
 
The piperidine ring is derived from lysine (Leete, 1992). Lysine is converted to 
cadaverine through decarboxylation by lysine decarboxylase (LDC). Cadaverine is then 
oxidatively deaminated by diamine oxidase (DAO) to 5-aminopentanal, which 
spontaneously cyclizes to piperideine.  
 
1.2.2. Nicotine, nornicotine, anabasine and anatabine formation 
The synthases responsible for nicotine, anabasine and anatabine have not been identified. 
There are two genes, A622 and BBL involved in coupling of pyridine, pyrrolidine and 
piperidine rings. Reductase gene A622 is a member of the PIP family of NADPH-
dependent reductases. In A622 suppressed cells, nicotinic acid N-glycoside and N-methyl 
pyrrolinium cation accumulate at the expense of all tobacco pyridine alkaloids (DeBoer et 
al., 2009). BBLs encode flavin-containing oxidases of berberine bridge enzyme family. 
When expression of the BBL genes was suppressed in tobacco hairy roots or in tobacco 
plants, nicotine production was highly reduced, with a gradual accumulation of 
dihydrometanicotine. Inhibition of BBL expression in cultured tobacco cells inhibited the 
formation of all pyridine alkaloids (Kajikawa et al., 2011).  
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Nicotine is composed of two heterocyclic rings, pyridine and pyrrolidine rings. 3, 6-
dihydronicotinic acid and 3, 6-dihydronicotine are postulated as potential intermediates 
during the condensation between nicotinic acid and N-methylpyrrolinium. These putative 
intermediates are proposed based on the observation that N-methylpyrrolidine is attached 
to the C-3 position of the pyridine ring, and the hydrogen at C-6 of nicotinic acid is lost 
during nicotine formation.  
 
Nornicotine is mainly, if not exclusively, synthesized through N′-demethylation of 
nicotine by nicotine demethylases, which belong to the CYP82E subfamily of 
cytochrome P450 monooxygenases. Cytochrome P450 enzymes are reviewed in section 
1.4.1 of this chapter. In tobacco, functional nicotine demethylases are encoded by 
CYP82E4 (Siminszky et al., 2005), CYP82E5v2 (Gavilano and Siminszky, 2007) and 
CYP82E10 (Lewis et al., 2010). CYP82E2 and CYP82E3 are present in the tobacco 
genome, but they encode for inactive enzymes and hence can be classified as 
pseudogenes. Besides nicotine demethylation, direct synthesis of nornicotine is implied 
by the existence of nornicotine in tobacco when all three demethylases are silenced 
(Lewis et al., 2010). In addition to its preferred N-methylputrescine substrate, the 
recombinant MPO1 enzyme can, to a lesser degree, utilize putrescine, resulting in an 
unmethylated pyrrolinium salt (Katoh et al., 2007). If the nicotine synthase can use this 
unmethylated pyrrolinium salt, nornicotine could be directly produced, bypassing 
nicotine. 
 
Anabasine is composed of pyridine and piperidine rings. As in nicotine and anatabine, 
nicotinic acid is incorporated into anabasine with elimination of a hydrogen at C-6 and 
loss of a carboxyl group. The formation of anatabine is quite different from that of 
anabasine, although they differ only by two hydrogens. The piperidine ring of anatabine 
is derived from nicotinic acid, not lysine. During the coupling of two molecules of 
nicotinic acid, one hydrogen atom at the C-6 position and both carboxyl groups are 
eliminated. 
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Figure 1.1. Alkaloid biosynthesis in tobacco plant (Nicotiana species) (Leete, 1992; 
Hakkinen et al., 2007; Kajikawa et al., 2011; Shoji and Hashimoto, 2011). The C-2 
carbons of ornthine and lysine, and the hydrogen at C-6 of nicotine acid are indicated 
using symbols to show their fates. Enzymes listed: ADC: arginine decarboxylase; AIH: 
agmatine deiminase; AO: aspartate oxidase; AP: aspartate oxidase; AS: arginase; LDC: 
lysine decarboxylase; MPO: methylputrescine oxidase; NCPAH: N-carbamoylputrescine 
amidohydrolase; ODC: ornithine decarboxylase; PMT: putrescine N-methyltransferase; 
QS: quinolinate synthase; QPRTase: quinolinate phosphoribosyltransferase; NND: 
nicotine N-demethylase. Hollow arrows mean that the reaction is spontaneous. 
Hypothetical intermediates are included in brackets. 
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1.3. Nicotine demethylation in tobacco 
1.3.1. Nicotine demethylation mechanism 
To study the mechanism of the nicotine demethylation in tobacco, nicotine with different 
positions labeled were incubated with tobacco plants and cultured cells. Results from [2′-
14
C, 2′-
3
H]nicotine feeding to  N. glauca excluded the oxidation at C- 2′ (Figure 1.2) 
(Leete and Chedekel, 1974). [4′,4′,5′,5′-
2
H4]nicotine incubation in N. alata root cultures 
ruled out the possibility of oxidation at C-5′ (Botte et al., 1997). N′-formylnornicotine is 
not the intermediate of demethylation supported by the observation of  [
13
C, 
2
H3-
methyl]nicotine and [1′-
15
N]nornicotine feeding (Bartholomeusz et al., 2005a) and is 
probably produced by the condensation of nornicotine and formaldehyde. CO2 formation 
during demethylation implies the involvement of tetrahydrofolate-mediated pathways of 
one-carbon metabolism and N′-hydroxymethylnornicotine (Mesnard et al., 2002). Based 
on these feeding results, two possible mechanisms were proposed for nicotine 
demethylation in N. tabacum. The hydrogen atom transfer pathway is the more probable 
one, according to CYP2A6 catalyzed nicotine demethylation in humans. 
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Figure 1.2. Two possible mechanisms in N′-demethylation of nicotine catalyzed by 
cytochrome P450 enzymes. (A) Metabolites profiles of nicotine feeding assays (Leete 
and Chedekel, 1974; Botte et al., 1997; Mesnard et al., 2002; Bartholomeusz et al., 
2005a). Nicotine demethylation is a direct oxidation of N′-methyl group. Label patterns 
of amino acids suggest that methyl group is transferred into one-carbon pathway. (B) 
Two possible mechanisms of nicotine demethylation based on general cytochrome P450 
catalyzed N-dealkylation reaction (Meunier et al., 2004): hydrogen atom transfer (HAT) 
versus single electron transfer (SET). HAT is a more probable mechanism based on the 
nicotine demethylation in humans. Note the hydrogen atom at the C-2′ position is not 
involved in either mechanism. Presumably (R)-nicotine is demethylated into (R)-
nornicotine, and (S)-nicotine is converted into (S)-nornicotine.                                                                                                                                                                      
 
 
1.3.2. Structure and function studies of tobacco nicotine demethylase enzymes 
During the process of screening nicotine demethylase mutants plants, a number of plants 
containing mutation(s) in demethylase genes were identified by sequencing, and the 
functionality of the demethylases was accessed by alkaloid analysis or in vitro enzyme 
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assays (Table 1.3). The sequence alignment of CYP82E4, CYP82E5v2 and CYP82E10 is 
shown in Figure S1.3. In tobacco, CYP82E3 is an ortholog of CYP82E4, with 95% 
sequence identity at the amino acid level, but it lacks nicotine N′-demethylase activity. 
The same amino acid substitution causes the functional turnover of CYP82E3 and 
CYP82E4 (Table 1.3) (Gavilano et al., 2007). Homologous model and molecular 
dynamics analysis of CYP82E4 and CYP82E3 and their mutants show the single amino 
acid mutation outside the active site region may have indirectly mediated the flexibility 
of the F-G and B-C loops through helix I, causing a functional turnover of the P450 
monooxygenase (Wang et al., 2011).  
 
 
Table 1.3. Functionality of tobacco nicotine demethylases possessing mutations 
(Gavilano et al., 2007; Xu et al., 2007b; Lewis et al., 2010). The functionalities of 
CYP82E3 and CYP82E10 variants were confirmed by in vitro enzyme assays. Except 
G900C mutation, the functionality of all CYP82E4 variants was accessed based on the 
nicotine and nornicotine ratio in tobacco plants. CYP82E5v2 with G1266A mutation lack 
the heme-binding domain which is essential for all P450 enzyme activity. 
Enzyme Mutation Amino acid Enzyme functionality 
CYP82E3 C900G C330W Functional 
    
CYP82E4 C113T P38L Wild type 
 C320T P107L Nonfunctional 
 G511A D171N Wild type 
 G601A E201K Wild type 
 G886A E296K Wild type 
 G900C W330C Nonfunctional 
 G986A W329Stop Nonfunctional 
 G1026A T342T Reduced conversion 
 G1092T K364N Nonfunctional 
 G1126A V376M Half of wild type 
 G1293A E431E Reduced conversion 
 C1372T P458S Nonfunctional 
 G1375A G459R Nonfunctional 
    
CYP82E5v2 G1266A W422Stop Nonfunctional 
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Enzyme Mutation Amino acid Enzyme functionality 
CYP82E10 G235A G79S Nonfunctional 
 C319T P107S Nonfunctional 
 G1030A A344T Wild type 
 C1141T P381S Nonfunctional 
 G1228A A410T Wild type 
 G1250A R417H Wild type 
 C1255T P419S A quarter of wild type 
 
 
 
1.3.3. Nicotine demethylase specificity 
Many nicotine demethylation investigations in tobacco used a series of nicotine analogs 
incubated with excised tobacco leaves and cultured tobacco cells (Table1.4) (Dawson, 
1951; Kisaki et al., 1978; Mesnard et al., 2001; Bartholomeusz et al., 2005b; Molinié et 
al., 2007). The feeding assays demonstrated that the tobacco could use a broad spectrum 
of compounds for the N-dealkylation reactions. Plant materials used in these feeding 
assays were all high demethylating tissues, implying that it could be the nicotine 
demethylases that catalyzed these reactions. It is interesting to note that many of the 
cytochrome P450s have a broad spectrum of possible substrates.  In humans, some CYPs 
(e.g., CYP2D6 and CYP2C9) are promiscuous and are responsible for the oxidation of 
approximately 70% of all therapeutic drugs. Instead of ―lock and key‖ concept, they seem 
to represent the ―induced fit‖ model in which the enzyme may accommodate very 
different substrates in the active center by virtue of relatively high flexibility (Pylypenko 
and Schlichting, 2004; Wade et al., 2004) and ability to undergo appropriate 
conformational changes (Denisov et al., 2005).  
 
  
Table 1.3 (continued) 
11 
 
Table 1.4. Specificity of demethylation process. Nicotine analogues were fed to 
tobacco leaves or cells. The compounds are classified based on whether the N-
dealkylation product is isolated. Details of the feeding assays are given in Table S1.2. 
 Compound structures 
N-
dealkylation 
      
  
  
Non-N-
dealkylation 
 
Note: Compounds with dashed border are found in tobacco. The compound with solid 
border has inconsistent reports of the detection of N-dealkylation production. 
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1.3.4. Evolution of nicotine demethylases in N. tabacum L. 
Nornicotine is typically a minor alkaloid in tobacco, accounting for about 3-5% of the 
total alkaloid content. In some tobacco populations, especially burley tobacco, individual 
plants known as ―converters‖ can demethylate as much as 97% of the nicotine to 
nornicotine during leaf senescence and curing. Cultivated tobacco (N. tabacum) is an 
allotetraploid species derived from the hybridization of ancestral N. tomentosiformis and 
N. sylvestris (Clarkson et al., 2005). Interestingly, the alkaloid profile of N. tabacum is 
different from that of either of its two progenitors. To explain such discrepancies, 
nicotine demethylase genes from tobacco and the two parents were isolated and 
functionally characterized. In tobacco, functional nicotine demethylases are encoded by 
CYP82E4 (Siminszky et al., 2005; Xu et al., 2007a), CYP82E5 (Gavilano and Siminszky, 
2007) and CYP82E10 (Lewis et al., 2010). CYP82E4 is silenced in nonconverters 
(Table1.5). Additionally, CYP82E2 and CYP82E3 are present in the tobacco genome, but 
they do not encode for active or functional enzymes. CYP82E3, CYP82E4 and CYP82E5 
are derived from N. tomentosiformis, while CYP82E2 and CYP82E10 are from N. 
sylvestris. Although being inactive in tobacco, all ancestral orthologues of CYP82E2, 
CYP82E3 and CYP82E4 encode active nicotine demethylases. CYP82E genes in modern 
tobacco have gained stable mutations in CYP82E2 and CYP82E3 and an unstable 
mutation in CYP82E4, after the hybridization of the two parental species (Chakrabarti et 
al., 2007).  
 
 
Table 1.5. Origin of nicotine demethylases found in N. tabacum L. genome. 
Demethylase genes Originality Function References 
CYP82E2 N. sylvestris Inactive, E375K and 
W422 mutations 
(Chakrabarti et al., 
2007) 
CYP82E3 N. tomentosiformis Inactive, W330C (Gavilano et al., 2007) 
CYP82E4 N. tomentosiformis Active, Unstable 
mutation 
(Gavilano et al., 2007) 
CYP82E5 N. tomentosiformis Active (Gavilano and 
Siminszky, 2007) 
CYP82E10 N. sylvestris Active (Lewis et al., 2010) 
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1.4. Theoretical studies of enzymes responsible for nicotine metabolism 
1.4.1. Cytochrome P450 
1.4.1.1. Primary sequence motif, nomenclature  
Cytochrome P450s are heme monoxygenases that catalyze diverse oxidation reactions 
and are biologically important for their roles in the oxidative transformation of both 
exogenous and endogenous small molecules. Broadly, cytochrome P450 enzymes 
biosynthesize endogenous molecules, inactivate/activate compounds with biological 
activities, and increase the hydrophilicity of compounds which facilitates their excretion 
and prevents toxic accumulation. They are able to catalyze the hydroxylation of saturated 
carbon-hydrogen bonds, the epoxidation of double bonds, the oxidation of heteroatoms, 
dealkylation reactions, oxidations of aromatics and many other reactions (Meunier et al., 
2004). Plant P450s participate in many biochemical pathways, including those devoted to 
the synthesis of plant products such as phenylpropanoids, alkaloids, terpenoids, lipids, 
cyanogenic glycosides, glucosinolates and plant growth regulators such as gibberellins, 
jasmonic acid and brassinosteroids (Chapple, 1998). 
 
There are three conservative P450 primary sequence motifs (Chapple, 1998): 1) 
consensus (P/I)PGPx(G/P)xP, proline-rich region immediately after the N-terminal 
hydrophobic helix. This region acts as a ―hinge‖ that is required for optimal orientation of 
the enzyme with regard to the membrane; 2) consensus (A/G)Gx(D/E)T(T/S), a 
threonine-containing binding pocket for the oxygen molecule; 3) FxxGx(H/R)xCxG, 
―P450 signature‖ motif and heme-binding domain. A cysteine is the proximal or ―fifth‖ 
ligand to the heme iron.  
 
All P450 systematic gene names include the designation CYP for cytochrome P450. The 
nomenclature for CYP isoforms is derived from amino acid sequence similarity 
determined through gene sequencing (Brown et al., 2008). Usually, amino acid sequences 
with more than 40% similarity are placed in the same family, designated by a number 
(e.g., CYP1), while those with greater than 55% similarity are grouped in the same 
subfamily, designated by a letter (e.g., CYP1A), and those with more than 97% identity 
comprise alleles, designated again with a number (e.g., CYP1A1) . The numbering of 
14 
 
plant P450 gene families begins with CYP71 through CYP99.  These family designations 
have now been exhausted and continue from CYP701. 
 
1.5.1.2. Enzymatic reaction cycle of cytochrome P450 
Because of the vast variety of reactions catalyzed by CYPs, the activities and properties 
of the many CYPs differ in many aspects. In general, the P450 catalytic cycle proceeds 
(mainly based on P450cam, a microbial cytochrome P450) as follows (Figure 1.3C): 1) 
The substrate enters into the active site of the enzyme and the bound substrate induces a 
change in the conformation of the active site, often displacing a water molecule from the 
distal axial coordination position of the heme iron (Figure 1.3A); 2) The change in the 
electronic state of the active site makes the heme a better electron sink and triggers an 
electron transfer of an electron from NAD(P)H via cytochrome P450 reductase or another 
associated reductase, which reduces the ferric heme iron to the ferrous state; 3) Molecular 
oxygen binds covalently to the distal axial coordination position of the heme iron. One 
electron from the iron(II) center and one from the triplet oxygen pair create an iron(III)-
oxygen bond; 4) A second electron is transferred via the electron-transport system, 
reducing the dioxygen adduct to a negatively charged peroxo group. This generates di-
negatively charged iron(III)-peroxo complex, which is a short-lived intermediate state. 
Electrons from NADPH are transferred one by one to P450s via cytochrome P450 
reductases (CPR). Both plant P450s and their reductases are usually bound via their N-
terminus to the cytoplasmic surface of the endoplasmic reticulum (Werck-Reichhart et al., 
2000); 5) The peroxo group formed in step 4 is rapidly protonated twice by local transfer 
from water or from surrounding amino acid side chains, releasing one water molecule, 
and forming a highly reactive species commonly referred to as P450 Compound 1 (Cpd I). 
P450 Compound 1 is most likely an iron(IV)oxo with additional oxidizing equivalent 
delocalized over the porphyrin and thiolate ligands (Por
·+
Fe(IV)-oxo); 6) Depending on 
the substrate and enzyme involved, P450 enzyme catalyze a wide variety of reactions. 
Figure 1.3C is an illustration of a hypothetical hydroxylation. After the product has been 
released from the active site, the enzyme returns to its original state, with a water 
molecule returning to occupy the distal coordination position of the iron nucleus.  
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Figure 1.3. The catalytic cycle of cytochrome P450.  (A) Prosthetic of cysteinato-heme 
enzymes: an iron(III) protoporphyrin-IX linked with a proximal cysteine ligand (Meunier 
et al., 2004). (B) Schematic organization of plant cytochrome P450 systems (Werck-
Reichhart et al., 2000; Bernhardt, 2006). CPR: cytochrome P450 reductase. (C) 
Schematic representation of the different intermediates generated during the catalytic 
cycle of cytochrome P450 (Denisov et al., 2005). 
 
 
1.4.2. Model studies of CYP-catalyzed nicotine demethylation 
In humans, nicotine is degraded principally by CYP2A6 through 5′-hydroxylation and N′-
demethylation is only a minor pathway (Table 1.6 and Figure 1.4). The preponderance of 
5′-hydroxylation over the N′-demethylation is by a factor of 19:1 (Murphy et al., 2005), 
confirmed by computational calculation (Li et al., 2010). Li et al. (2010) performed a 
series of first-principle electronic structure calculations to examine the fundamental 
reaction pathways for 5′-hydroxylation and N′-demethylation of nicotine catalyzed by the 
active species of P450 enzyme, Cpd I. N′-demethylation of nicotine involves a N′-
methylhydroxylation followed by the decomposition of N′-(hydroxymethyl)nornicotine. 
The N′-methylhydroxylation of nicotine occurs through a stepwise process, that is, a bond 
activation hydrogen transfer step and a rebound step. The hydrogen transfer step is rate-
determinating. After the N′-methylhydroxylation process, N′-(hydroxymethyl)nornicotine 
decomposes to nornicotine and formaldehyde with a very low energy barrier. This 
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decomposition process occurs on the deprotonated N′-(hydroxymethyl)nornicotine 
species and is assisted by a water molecule. 
 
 
Table 1.6. Species differences in nicotine metabolism. Details of how nicotine is 
metabolized by microbes and humans are provided in Supplement S1.1 and S1.2. 
Species Substrate Enzymes Metabolites Reference 
Tobacco  
(Nicotiana L.) 
 
1.  CYP82E4(major), 
CYP82E5, CYP82E10 [1] 
2.  Unknown 
1.  Nornicotine [1] 
2.  Cotinine [2] 
[1] (Lewis et al., 
2010); [2] (Botte et 
al., 1997) 
Human  
(Homo sapiens) 
 
1.  CYP2A6(major), 
CYP2B6, CYP2A13 [1] 
2.  CYP2A6 [2] 
3.  CYP2A6, CYP2B6, 
CYP2A13 [3] 
4.  FMO3 [4] 
5.  Amine N-
methyltransferase  
6.  UGT1A3, UGT1A4 
(major), UGT1A9 [6] 
1.  5′-Hydroxynicotine [1] 
2.  2′-Hydroxynicotine [2] 
3.  Nornicotine [3] 
4.  Trans-nicotine N-1′-
oxide 
5.  Nicotine isomethonium 
ion [5] 
6.  Nicotine glucuronide [6] 
[1] (Flammang et al., 
1992); [2] (Hecht et 
al., 2000); [3] 
(Yamanaka et al., 
2005); [4] (Park et 
al., 1993) 
[5] (Crooks and 
Godin, 1988); [6] 
(Kuehl and Murphy, 
2003) 
Bacterial 
 
1.  Nicotine dehydrogenase 
[1] 
2. nicA [2] 
3. Unknown  
4. Unknown  
1.  6-Hydroxynicotine [1] 
2. N-Methylmyosmine 
3. Myosmine [3] 
4. 5′-Hydroxylation [3] 
[1] (Freudenberg et 
al., 1988); [2] (Tang 
et al., 2009); [3] 
(Wang et al., 2012) 
Fungi 
(Aspergillus 
oryzae 112822) 
 
1.  Unknown  1.  Nornicotine [1] [1] (Meng et al., 
2010) 
Note: FMO3: Flavin-Containing Monooxygenase 3; UGT1A3: UDP-
glucuronosyltransferase 1A3. 
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Figure 1.4. Human CYP2A6-catalyzed demethylation of (S)-nicotine (Li et al., 2010). 
 
 
The CYP2A6-catalyzed 5′-hydroxylation of nicotine has been studied by quantum 
mechanics (Li et al., 2010), molecular docking, molecular dynamics simulations, and 
binding free energy calculations, in combination with first-principles electronic structure 
calculations accounting for solvent effects (Li et al., 2011a). The 5′-hydroxylation 
process is similar to the N-methylhydroxylation, namely, that a rate-determining 
hydrogen transfer step in a two-state reactivity mechanism is followed by a rebound step. 
(S)-nicotine in the active site of the enzyme exists in the neutral state, in contrast with the 
protonated state in aqueous solution. CYP2A6-catalyzed (S)-nicotine 5′-hydroxylation 
proceeds mainly with the stereoselective loss of the trans-5′-hydrogen. The calculated 
overall stereoselectivity is 97% favoring the trans-5′-hydroxylation.The stereoselectivity 
of the reaction originates from the different binding affinity of two conformations of (S)-
nicotine free base with CYP2A6 (Figure1.5).  
 
Recently, the CYP2A6 and CYP2A13 crystal structures were solved with nicotine soaked 
into the CYP crystals (DeVore and Scott, 2012). Both CYP2A6 and CYP2A13 oxidize 
nicotine at various locations on the methylpyrrolidine ring (Table 1.6). Although the 
CYP2A6 and CYP2A13 enzymes are 94% identical, the catalytic efficiency of CYP2A13 
with nicotine is over 20-fold higher than CYP2A6 (Bao et al., 2005). DeVore and Scott 
(2012) investigated the structural differences in nicotine binding between CYP2A6 and 
CYP2A13 by determining the structures of both complexes. In CYP2A13 the 
methylpyrrolidine ring is oriented more parallel to the heme plane, while in CYP2A6 the 
orientation is closer to perpendicular. Another difference is that in CYP2A6 the N297 
side chain is rotated, slightly farther away from nicotine, compared to CYP2A13 
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structure. N297 is important for the orientation of several ligands in the CYP2A6 active 
site (Schlicht et al., 2009). 
 
 
      
Figure 1.5. CYP2A6-catalyzed 5′-hydroxylation of (S)-nicotine. (A) Representative 
binding structure of Compound I of CYP2A6 with trans-5′-hydrogen of (S)-nicotine. 
Atoms in blue are subjected to the quantum mechanical calculation. The boundary carbon 
atom (red) is treated with improved pseudobond parameters. All other atoms are treated 
with the molecular mechanical method. (B) CYP2A6-catalyzed 5′-hydroxylation of (S)-
nicotine. CYP2A6 catalyzes hydroxylation of nicotine at prochiral 5′-position to form the 
∆
1
′ 
(5′)
 -iminium ion. Trans-5′-hydrogen is stereoselectively used by CYP2A6. 
  
 
 
Several bacterial species are able to grow on nicotine. The pathway for oxidative 
degradation of nicotine in Arthrobacter nicotinovorans includes two genetically and 
structurally unrelated flavoenzymes, 6-hydroxy-L-nicotine oxidase (6HLNO) and 6-
hydroxy-D-nicotine oxidase (6HDNO), which act with absolute stereospecificity on the 
L- (S) and D- (R) forms, respectively, of 6-hydroxy-nicotine (Figure1.6). Crystal 
structures of 6HLNO and 6HDNO have been solved and stereoselectivity of these two 
enzymes has been studied (Koetter and Schulz, 2005; Kachalova et al., 2010). The 
orientation of the chiral center atom C-2′ of 6-hydroxy-L-nicotine with respect to the 
flavin N-5 atom is suitable for dehydrogenation by abstraction of a hydrogen from C-2′ to 
the flavin. The absolute stereospecificity of the enzymatic reaction is suggested to be the 
difference in the orientation of the L- and D-substrates with respect to the flavin. 
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Figure 1.6. Oxidative degradation of nicotine in Arthrobacter nicotinovorans. NDH: 
nicotine dehydrogenase; 6HLNO: 6-hydroxy-L-nicotine oxidases; 6HDNO: 6-hydroxy-
D-nicotine oxidases 
 
 
 
Bacterial cytochrome P450 101 (P450cam) is a well studied enzyme and used as model for 
structure and function relationship investigation. Nicotine is a non-native substrate of 
P450cam, and used to probe the active site of P450cam. P450cam comes from Pseudomonas 
putida, which has been used to prepare (R)-nicotine (Edwards and McCuen, 1983). Based 
on P450cam crystal structure, molecular dynamics calculations of nicotine and P450cam 
complex predicate that P450cam binds (R)-nicotine 1.4-fold faster than (S)-nicotine, and 
the product formation occurs at a faster rate at the 5′ methylene group than at the N′-
methyl group of the pyrrolidine ring for both enantiomers, which were confirmed by a 
parallel experimental study (Jones et al., 1993). In vitro incubation of P450cam and (S)-
nicotine shows that P450cam, like human CYP2A6, catalyzes the stereoselective, 
energetically less favorable loss of the trans-5′-hydrogen (Carlson et al., 1995). Despite 
the existence of a theoretical model that is consistent with the observed distribution of 
monooxygenation products, it is interesting to note that the primary binding mode of 
nicotine is unproductive (Figure1.7) (Strickler et al., 2003). Crystallographic and 
spectroscopic data indicate direct coordination of nicotine pyridine nitrogen with the 
heme iron. Reduction of the heme from Fe(III) to Fe(II) and introduction of carbon 
monoxide into crystals of the nicotine- P450cam complex, to simulate molecular oxygen 
binding, produces reorientation of the nicotine. So P450cam -nicotine interactions 
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exhibited complicated behavior, questioning the value of a single crystal structure for 
binding mode study of a given substrate-enzyme complex.  
 
 
Figure 1.7. Hydroxylation of nicotine by P450cam, based on crystallographic data 
(Strickler et al., 2003). 
 
 
1.5. Compartmentation and trafficking of nicotine 
1.5.1. Long distance translocation from roots to leaves 
Nicotine is produced in tobacco roots (Dawson, 1942), probably only in root tips (Solt, 
1957), then translocated to leaf via xylem (Guthrie et al., 1962) and finally deposited in 
leaf vacuole. As much as 60 mM of nicotine accumulates in the vacuoles of the leaf 
epidermal cells at the leaf tip (Lochmann et al., 2001). Nicotine demethylation can occur 
in both root (Mizusaki et al., 1965) and leaf (Dawson, 1945), mainly in aging leaves 
(Wernsman and Matzinger, 1968). The accumulation patterns of nicotine and nornicotine 
in leaf have been investigated (Burton et al., 1992)(Figure 1.8). The four main alkaloids 
are found in tobacco stem sap (Wada et al., 1959), suggesting all four alkaloids can be 
translocated from root to leaf. About 0.1 mM nicotine is present in the xylem fluid 
(Baldwin, 1989). Results from metabolite studies are confirmed by the expressions of 
genes encoding enzymes important for nicotine biosynthesis. The important genes MPO, 
QPRTase, A622 and BBL in N. tabacum are all expressed in root, not in leaf (Table1.7 
and Figure 1.9). The putative alkaloid biosynthetic gene A622 expresses in the first 
10mm of root tips, which is consistent with the results obtained from excised root culture 
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study (Solt, 1957). The expression patterns of nicotine demethylase genes are also 
consistent with where nornicotine formation and accumulation occur.  
 
 
                 
Figure 1.8. Nicotine and nornicotine distribution in leaf (Burton et al., 1992). The air-
cured leaf of dark tobacco Ky171 was cut into 7cm long X 4cm wide segments along the 
length of the leaf. The mirror image segments of the lamina were combined and analyzed. 
 
 
 
Table 1.7. Spatial expression patterns of genes encoding nicotine biosynthesis 
pathway enzymes in tissues. 
Genes Expression location Material Method Reference 
 Leaf Stem Root    
PMT +* - +** N. tabacum RNA gel blot[1]; RT-
PCR and immunoblot 
[2] 
[1] (Hibi et al., 1994; Katoh et 
al., 2007); [2] (Sachan and 
Falcone, 2002) 
MPO - - + N. tabacum RNA gel blot (Katoh et al., 2007)  
QPRTase - ND + N. tabacum RNA gel blot (Sinclair et al., 2000) 
 + ND + N. glauca RNA gel blot (Sinclair et al., 2000)  
A622 - -
[1]/+[3] 
+** N. tabacum RT-PCR[1]; RNA gel 
blot[2, 3]; 
immunoblot[3] 
[1] (Kajikawa et al., 2009); [2] 
(Hibi et al., 1994); [3] (Shoji et 
al., 2002)  
 - ND + N. 
sylvestris 
Northern analysis (Sinclair et al., 2004) 
 + * ND + N. glauca Northern analysis (Sinclair et al., 2004) 
BBL - - + N. tabacum qRT-PCR (Kajikawa et al., 2011) 
CYP82E4 + * + + N. tabacum Promoter fused with 
GUS[1]; qRT-PCR[2] 
[1] (Chakrabarti et al., 2008); 
[2] (Gavilano and Siminszky, 
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Genes Expression location Material Method Reference 
 Leaf Stem Root    
2007; Xu et al., 2007a)  
CYP82E5 + ND ND N. tabacum qRT-PCR (Gavilano and Siminszky, 
2007) 
CYP82E10 ND ND + N. tabacum Root specific cDNA 
library 
(Lewis et al., 2010) 
Note: ND: not determined; * low level before induction; ** first 10mm root tip. 
 
 
 
 
 
Figure 1.9. A simplified diagram of nicotine synthesis in Nicotiana. Enzymes listed: 
BBL: berberine bridge enzyme-like protein; E4/ E5/ E10: nicotine N-demethylase 
CYP82E4/ CYP82E5/ CYP82E10; MPO: methylputrescine oxidase; PMT: putrescine N-
methyltransferase; QPRTase: quinolinate phosphoribosyltransferase. Hollow arrow 
means the reaction is spontaneous.  
 
 
Jasmonate-inducible Alkaloid Transporter 1 (NtJAT1) and a pair of homologous proteins 
NtMATE1 and NtMATE2 have been identified as tonoplast-localized nicotine 
transporters in tobacco (Figure1.10) (Morita et al., 2009; Shoji et al., 2009). NtJAT1 and 
NtMATEs are Multidrug And Toxic compound Extrusion (MATE)-type transporters, 
which have been shown to efflux low-molecular weight compounds as drug/H
+
 or 
drug/Na
+
 antiport systems. NtJAT1 is expressed in leaves, stems and roots, and localized 
to the tonoplast in leaves. Biochemical analysis demonstrated that NtJAT1 functioned as 
a H
+
-antiporter, transporting nicotine and anabasine (Morita et al., 2009). In contrast to 
Table 1.7 (continued) 
23 
 
NtJAT1, NtMATE genes are specifically expressed in nicotine-producing root cells and 
localized to the tonoplast (Shoji et al., 2009). 
 
 
Figure 1.10. A model of nicotine translocation and accumulation in leaf cells from 
root cells (Morita et al., 2009; Shoji et al., 2009; Shoji and Hashimoto, 2011).  
 
 
1.5.2. Cell type 
Alkaloids generally accumulate in specific cell types owing to their cytotoxicity and 
probable role in plant defense responses (Ziegler and Facchini, 2008). The early NAD 
biosynthetic pathway for tobacco alkaloids biosynthesis consists of aspartate oxidase (EC 
1.4.3.16), quinolinate synthase, and quinolinic acid phosphoribosyl transferase (EC 
2.4.2.19), all of which are localized in the plastid and are coordinately regulated with 
nicotine biosynthesis (Figure1.1) (Sato et al., 2007). PMT and A622 are expressed 
strongly in epidermis and cortex cells of the tobacco root tip, and moderately in the 
outermost layer of the cortex, and in parenchyma cells surrounding the xylem of the 
differentiated region of the root (Sato et al., 2007). CYP82E4 promoter fused GUS is 
expressed in epidermis, palisade parenchyma, spongy mesophyll, trichome, and petiole of 
leaf (Chakrabarti et al., 2008). Promoter regulated gene expression is directed to pith and 
cortex region of the stem constitutively. 
 
1.6. Pharmacological effects of enantiomers of nicotine and TSNAs 
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1.6.1. Pharmacological effects of nicotine and TSNAs 
Nicotine is not carcinogenic, but is pharmacologically active in animals. Nicotinic 
cholinergic receptors are ligand-gated ion channels. When nicotine binds to the outside of 
the channel, the channel opens allowing the entry of cations, including sodium and 
calcium. Nicotinic receptor facilitates the release of neurotransmitters, such as dopamine, 
norepinephrine, acetylcholine, serotonin, GABA, glutamate, and endorphins. These 
neurotransmitters mediate various behaviors associated with nicotine (Benowitz, 2008). 
 
In contrast to nicotine some tobacco-specific nitrosamines (TSNAs) are carcinogenic and 
seven TSNAs have been identified in tobacco products: N′-nitrosonornicotine (NNN), 4-
(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), 4-(methylnitrosamino)-1-(3-
pyridyl)-1-butanol (NNAL), N′-nitrosoanatabine (NAT), N′-nitrosoanabasine (NAB), : 4-
(methylnitrosamino)-4-(3-pyridyl)-1-butanol (iso-NNAL), and 4-(methylnitrosamino)-4-
(3-pyridyl)butanoic acid (iso-NNAC) (Figure1.11) (Hecht, 1998). They are nitrosated 
products of four main alkaloids formed during the tobacco curing process. NNN, NNK, 
and NAT generally occur in greater quantities than the others, and NNK, NNAL, and 
NNN are the most carcinogenic. NAB, NAT, iso-NNAL and iso-NNAC have shown 
weak or no carcinogenic activity. NNK is the strongest carcinogen among the TSNAs in 
rodents. The TSNAs are procarcinogens, agents that require metabolic activation. The 
carcinogenicity of NNK and NNN is dependent on its metabolic activation. The primary 
mechanism of NNK/NNN-mediated carcinogenesis is metabolic activation by 
cytochrome P450 enzymes and generation of unstable metabolites (electrophiles) that 
react with DNA and result in appreciable genotoxicity (Hecht, 2008).  
 
 
1.6.2. Pharmacological effects of the enantiomers of nicotine and TSNAs 
The two nicotine enantiomers behave differently in human. The LD50S for intravenous 
administration of (R)-nicotine in several animal species have been approximately 18 
times higher than that of (S)-nicotine (Pogocki et al., 2007). Also a significantly lower 
level of toxic and carcinogenic metabolites is produced from (R)-nicotine. Based on the 
overall cytotoxicity of the compound and its metabolites, it appears that (R)-nicotine is 
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approximately 80-times less cytotoxic than (S)-nicotine (Yildiz et al., 1998). Interestingly, 
behavioral studies have shown that the subjective hedonic effects among the smokers 
caused by (R)-nicotine are of an intensity comparable to that caused by the (S)-
enantiomer (Thuerauf et al., 2000). Therefore, the R form of nicotine is suggested to be 
used as a smoke cessation agent. 
 
(S)-NNN undergoes significantly more 2-hydroxylation than (R)-NNN in cultured rat 
esophagus and in vivo in rats. In rats treated with racemic NNN, 66% of 2-hydroxylation 
metabolites are from (S)-NNN, while 74% of the 5-hydroxylation products are produced 
from (R)-NNN (McIntee and Hecht, 2000). 2-hydroxylation of NNN is the major 
metabolic activation pathway, suggesting carcinogenicity of (S)-NNN may be greater 
than that of (R)-NNN. 
 
 
  
26 
 
 
 
 
Figure 1.11. Structures and biological effects of tobacco alkaloids and tobacco-
specific nitrosamines. (A) Structures of tobacco-specific nitrosamines and tobacco 
alkaloid precursors (Hecht, 1998; Carmella et al., 2000). With the exception of NNA, all 
have been detected in tobacco products. NNK, NNAL, and NNN are the most 
carcinogenic of the tobacco-specific nitrosamines that have been identified in tobacco 
products. (B) Schematic representation of pathways associated with the biological role of 
nicotine demethylation (McIntee and Hecht, 2000; Pogocki et al., 2007; Benowitz, 2008; 
Hecht, 2008). Green/cyan arrow represents S/R isomer predominant pathway, 
respectively. Dotted arrow means minor pathway. iso-NNAL: 4-(methylnitrosamino)-4-
(3-pyridyl)-1-butanol;  iso-NNAC: 4-(methylnitrosamino)-4-(3-pyridyl)butanoic acid; 
NAB: N′-nitrosoanabasine; NNAL: 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol; NAT: 
N′-nitrosoanatabine; NNA: 4-(methylnitrosamino)-4-(3-pyridyl)butanal; NNK: 4-
(methylnitrosamino)-1-(3-pyridyl)-1-butanone;  NNN: N′-nitrosonornicotine. 
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1.7. Experimental aim of this dissertation 
Despite extensive studies, the nornicotine enantiomeric composition in tobacco leaf 
cannot be explained by current data. In tobacco about 0.2 % of the nicotine is the (R)-
enantiomer (Armstrong et al., 1998), whereas nornicotine displays considerably high and 
variable (R)-enantiomer composition (4 to 75 % of total nornicotine) in leaf (Fannin et al., 
1996; Armstrong et al., 1999; Liu et al., 2008). Different alkaloid enantiomers have 
different pharmacological activities as previously reviewed in section 1.6.2. 
Understanding the mechanisms behind the discrepancies of the enantiomeric composition 
between substrate and product will not only help to better understand the accumulation of 
enantiomers of nicotine and nornicotine in tobacco leaves, but to provide a basis for 
future manipulation of the enantiomeric composition of nicotine, nornicotine and their 
metabolites. The goal of this dissertation is to explore possible reasons and to identify the 
most probable mechanism behind the variable nornicotine composition (Figure 1.12). 
 
 
 
 
Figure 1.12. Possible mechanisms for high and variable (R)-nornicotine percentage 
in tobacco leaf. 
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Chapter 2. Variable nornicotine enantiomeric composition caused by nicotine 
demethylase CYP82E4 in tobacco leaf 
2.1. Introduction 
2.1.1. Highly variable nornicotine enantiomeric composition in tobacco 
Nornicotine is one of the four major alkaloids in Nicotiana tabacum L. Nornicotine is, at 
least mainly, synthesized by demethylation of nicotine which is produced in roots and 
transported to leaves and accumulates in the vacuole (Shitan and Yazaki, 2007). However, 
the details of nornicotine biosynthesis and translocation are not clear and recently 
published results of nicotine and nornicotine enantiomeric composition cannot be 
explained based on current knowledge. The enantiomeric fraction of nornicotine (EFnnic) 
(0.05-0.70) is much higher than what is expected from enantiomeric fraction of nicotine 
(EFnic) (0.001-0.004) (Table 2.1). Enantiomer fraction (EFx) is used to represent the 
proportion of R enantiomer compared to the S enantiomer of compound x (Harner et al., 
2000). 
 
Investigating nornicotine biosynthesis has both fundamental metabolic and practical 
applications. Nornicotine has received much attention due to its relationship to tobacco-
specific nitrosamine N′-nitrosonornicotine (NNN) which is carcinogenic in many 
bioassays. Understanding nornicotine biosynthesis and accumulation will greatly 
facilitate the interpretation of the enantiomeric components of nicotine and NNN (Figure 
2.1.). Chiral compounds with identical physical and chemical properties in achiral 
environments, generally exhibit different biological and toxicological activities, because 
each enantiomer can enantioselectively interact with enzymes and biological receptors in 
organisms (Seifert and Dove, 2009). For example, NNN is present in unburned tobacco 
as well as cigarette smoke, and the carcinogenicity of (S)-NNN is suggested to be greater 
than (R)-NNN in rat esophagus (McIntee and Hecht, 2000; Lao et al., 2007). Nicotine 
also exhibit different biological activity. (R)-nicotine has many of the same 
physicochemical properties as (S)-nicotine, but (S)-nicotine has a greater level of toxicity. 
LD50s for intravenous administration of (R)-nicotine in several species of animals have 
been approximately 18 times higher than that of (S)-nicotine, which means (R)-nicotine 
is less potent. This suggests a potential application for (R)-nicotine as a therapeutic agent 
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(Pogocki et al., 2007). Since nornicotine is the major metabolite of nicotine and precursor 
of NNN, we may minimize the harmful effects of cigarettes through adjusting the 
enantiomeric ratio of nicotine and NNN. 
 
 
Table 2.1. Enantiomer fraction, EF, of nicotine and nornicotine in tobacco 
(Nicotiana tabacum L.). 
 EF Material References 
Nicotine 0.001-0.004 Leaves  (Armstrong et al., 1998) 
 <0.025 Leaves (Perfetti and Coleman, 1998) 
    
    
Nornicotine Predominantly R Roots (Kisaki and Tamaki, 1960) 
 0.14-0.25 Leaves (Armstrong et al., 1999) 
 0.10-0.40 Leaves (Liu et al., 2008) 
 0.30-0.70 Leaves (Fannin et al., 1996) 
 0.05-0.43 Leaves (Perfetti and Coleman, 1998) 
 
 
 
 
Figure 2.1. Structures of R and S enantiomers of nicotine, nornicotine and N′-
nitrosonornicotine. 
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2.1.2. Putative reasons for wide range of EFnic 
There are several reasons potentially responsible for the large and variable EFnnic (Figure 
2.2.). Among these putative reasons, enantioselective demethylation likely plays a major 
role. Stereoselective translocation, enantioselective metabolism and direct synthesis may 
contribute along with enantioselective demethylation. Racemization is unlikely a reason 
for variable nornicotine composition, but we cannot exclude the possibility.  
 
The most plausible explanation for variable composition of nornicotine is 
enantioselective demethylation of nicotine. Demethylation rates of (R)- and (S)- nicotine 
have been reported to be different (Mesnard et al., 2001; Bush et al., 2003). Exogenous 
nicotine feeding assays in cell culture (Mesnard et al., 2001) and plant tissue (Bush et al., 
2003) demonstrate the rate of (R)-nicotine demethylation is higher than (S)-nicotine. 
There are three functional nicotine demethylases in tobacco (Siminszky et al., 2005; 
Gavilano and Siminszky, 2007; Xu et al., 2007a; Lewis et al., 2010). Each demethylase 
may have its own preference for nicotine enantiomers. Throughout the life cycle of a 
tobacco plant, different expressions and activities of nicotine demethylases can contribute 
to the variable values of nornicotine enantiomeric composition.  
 
Also, stereoselective degradation of (S)-nornicotine may contribute to the variable EFnnic. 
Kisaki and Tamaki (1966) found that (R)-nornicotine was recovered more when feeding 
(R) and (S)-nornicotine to excised leaves of N. tabacum, respectively. This result implied 
the enantioselective degradation of (S)-nornicotine. Cell culture feeding assay supported 
Kisaki and Tamaki‘s work, but myosmine level, the main product of nornicotine 
degradation, was the same (Mesnard et al., 2001). This could be due to the possibility that 
myosmine is degraded as fast as it is formed, or that other intermediates are involved.   
 
Stereoselective translocation may play a minor role. Transporters which are strictly 
stereoselective are found in plants (Bandell and Lolkema, 1999) and animals (Luurtsema 
et al., 2004). ABC transporter is a common transporter for plant secondary metabolites, 
and is a potential candidate for nicotine and nornicotine transportation. However, the first 
discovered transporter for vacuolar transport of nicotine in Nicotiana tabacum L. is a 
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multidrug and toxic compound extrusion-type (MATE) transporters (Morita et al., 2009; 
Shoji et al., 2009). There is still no report of a nornicotine transporter and 
stereoselectivity of the transporter.   
 
Nornicotine may be directly synthesized which would be a possible explanation of the 
varying EFnnic. In the biosynthetic pathway of nicotine, putrescine is first N-methylated 
by putrescine N-methyltransferae. The product N-methylputrescine is then deaminated 
oxidatively to 4-methylaminobutanal, which spontaneously cyclizes to give the N-
methylpyrrolinium. This oxidative deamination reaction is catalyzed by N-
methylputrescine oxidase (MPO). The N-methylpyrrolinium condense with nicotinic 
acid-derived metabolite 1,2-dihydropyridine to give nicotine in tobacco (Leete, 1992). In 
addition to its preferred N-methylputrescine substrate, recombinant MPO1 enzyme could 
to a lesser degree utilize putrescine, probably resulting in an unmethylated pyrrolinium 
salt (Katoh et al., 2007). If the nicotine synthase can use this unmethylated pyrrolinium 
salt, nornicotine could be directly produced, bypassing nicotine. Mutant plants with 
knockouts of all three demethylases still contain some nornicotine, implying the existence 
of the direct synthesis of nornicotine (Lewis et al., 2010). 
 
Racemization during (Kisaki and Tamaki, 1961a) or after demethylation (Leete, 1992) 
was proposed for (R)-nornicotine production. (R)-nornicotine may come from the 
racemization of (S)-nornicotine (Leete, 1992). Chemically nornicotine may be racemized 
in the presence of pyridoxal (Jacob, 1996), which is present in green plants as natural 
forms of vitamin B6. Nornicotine derived from pure (S)-nicotine was partially racemized 
in N. tabacum during demethylation, and feeding (S)-nornicotine only (S)-nornicotine 
was recovered, implying that the racemization occurs during demethylation (Kisaki and 
Tamaki, 1961b). However, feeding one form of nicotine to cell cultures (Mesnard et al., 
2001) and tobacco leaves (Fannin et al., 1996) only resulted in the corresponding form of 
nornicotine being recovered which makes racemization the unlikely explanation for (R)-
nornicotine production.  
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In this paper, EFnnic in different tobacco lines and tissues were investigated to validate the 
variable results in the literature. Induction and suppression of nicotine demethylase 
CYP82E4 demonstrate that CYP82E4 reduces EFnnic in tobacco and produces a variable 
EFnnic. 
 
 
Figure 2.2. Possible mechanisms to account for the high and variable EFnnic in 
tobacco leaf. 
 
 
2.2. Results 
2.2.1. EFnnic in among different lines and tissues 
To verify the literature reports, tobacco varieties with different nicotine demethylation 
capability were chosen. Nornicotine composition of different tissues from burley tobacco 
lines TN90LC, L8, RM52 and RNAi were analyzed. TN90LC is a widely used 
commercial variety. L8 is a breeding line for root disease resistance. RM52 is a high 
nicotine tobacco line. The RNAi line had nicotine demethylases silenced. A wide range 
of EFnnic was measured (Figure2.3), which confirms the earlier literature reports. 
Considering the 0.002 EFnic (Armstrong et al., 1998), one may wonder what is the source 
of the additional (R)-nornicotine, resulting in the elevated EFnnic. 
 
Further investigations of each enantiomer of nornicotine found different patterns among 
TN90LC, L8, RM52 and RNAi plants (Figure2.4). There was no correlation between 
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demethylation and EFnnic. The R or S form of nornicotine changes individually not 
proportionally with the other form. Lamina from lower leaves (referred to bottom lamina) 
from RNAi and RM52 plants have lower EFnnic than L8 and TN90LC. Reasons for these 
results are different. RNAi plants had a lower (R)-nornicotine level than L8 and TN90LC, 
while RM52 had a much higher (S)-nornicotine level. 
 
 
 
Figure 2.3. There is wide range of EFnnic in different tobacco lines.  Four tobacco lines 
have different nicotine demethylation abilities. All samples were from mature stage of 
plant growth and were analyzed for alkaloid levels and nornicotine composition. 
Demethylation is calculated based on nicotine and nornicotine levels and EFnnic is 
calculated based on (R)-nornicotine and (S)-nornicotine levels. L8 is a tobacco breeding 
line for disease resistance. TN90LC is a commercial tobacco cultivar. RM52 is a tobacco 
line with high nicotine demethylation ability. Nicotine demethylases in RNAi plants are 
silenced by RNAi technique (Gavilano et al., 2006). Each bar is an average of four plants. 
Error bar represents the standard deviation. 
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Figure 2.4. (R)-nornicotine (A) and (S)-nornicotine (B) accumulate to  different 
levels in different tissues of four tobacco lines. Four tobacco lines have different 
nicotine demethylation abilities. All samples were from mature stage of plant growth and 
were analyzed for alkaloid levels and nornicotine composition. L8 is a tobacco breeding 
line for disease resistance. TN90LC is a commercial tobacco cultivar. RM52 is a tobacco 
line with high nicotine demethylation ability. Nicotine demethylases in RNAi plants are 
silenced by RNAi technique (Gavilano et al., 2006). Each bar is an average of four plants. 
Error bar represents the standard deviation. 
 
 
 
2.2.2. Ethephon-inducted CYP82E4 expression associated with decreased EFnnic 
As mentioned above, several reasons can account for the high and variable EFnnic. To 
investigate how demethylation affects EFnnic, tobaccos with different nicotine 
demethylating capability were chosen and treated with ethephon. Ethephon promotes leaf 
senescence and stimulates nicotine demethylation (Jack and Bush, 2007) and CYP82E4 
expression (Chakrabarti et al., 2008). Compared to freeze-dried leaves, ethephon treated 
converter leaves had increased nicotine demethylation (dotted line in Figure2.5.), and 
decreased EFnnic. For individual nornicotine isomer levels (Figure 2.6.), both (R)- and 
(S)- nornicotine amounts increased after ethephon induction. But (S)-nornicotine 
increased much more than (R)-nornicotine, which makes the relative (R)-nornicotine 
level decrease. Since CYP82E4 expression is dramatically induced by ethephon and E4 is 
the major demethylase in converter plants (Gavilano et al., 2006), we can infer that at 
mature growth stage when E4 expression will be induced, (S)-nornicotine is produced 
more than (R)-nornicotine which results in increased demethylation and decreased EFnnic. 
Why does (R)-nornicotine increase less? It is probably due to the limitation of (R)-
nicotine substrate. It is also noteworthy that freeze-dried leaf and roots have similar, if 
not equivalent, EFnnic and demethylation (Figure 2.5.).   
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Figure 2.5. EFnnic decreases after the induction of nicotine demethylation. All 
tobacco lines were grown in greenhouse. Two top leaves and roots from each line were 
sampled at two weeks after topping. One leaf was freeze-dried used as control, and the 
other one was sprayed 0.1% ethephon and air-dried. All dried samples were analyzed for 
alkaloid levels and nornicotine composition. Demethylation is calculated based on 
nicotine and nornicotine levels and EFnnic is calculated based on (R)-nornicotine and (S)-
nornicotine levels. RNAi: RNAi plant DH98-325-6 RNAi #2-8; LC: low converter 
DH98-325-5; C: converter DH98-325-6. 
 
 
            
Figure 2.6. (R)-nornicotine (A) and (S)-nornicotine (B) increase differently after 
ethephon induction of nicotine demethylase. All tobacco lines were grown in 
greenhouse. Two top leaves and roots from each line were sampled at two weeks after 
topping. One leaf was freeze-dried used as control, and the other one was sprayed 0.1% 
ethephon and air-dried. All dried samples were analyzed for alkaloid levels and 
nornicotine composition. RNAi: RNAi plant DH98-325-6 RNAi #2-8; LC: low converter 
DH98-325-5; C: converter DH98-325-6. 
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2.2.3. Nicotine demethylase CYP82E4 mutant results in increased EFnnic  
To further confirm CYP82E4 effects, e4 mutants (Lewis et al., 2010) were analyzed for 
nornicotine enantiomeric composition. Tobacco line DH98-325-6 was chosen as parent 
for EMS mutation (―P‖ in Figure 2.7). Mutants with homologous mutation in CYP82E4 
gene and their backcross with parental line were grown in the field, and cured leaves 
were analyzed for alkaloid levels and nornicotine composition. Demethylation is used to 
confirm that the CYP82E4 is effectively silenced.  
 
Four e4 mutants, e4 #1-4, have much lower demethylation than the parent line (P), which 
means they are effective mutant lines (Figure 2.7.). All these effective mutant lines have 
high EFnnic, like control TN90LC. Four effective mutants were backcrossed with 
converter parent to produce four heterozygous lines (F1 plants). These four backcross 
lines have increased nicotine demethylation and decreased EFnnic. The profile of four 
effective e4 mutants and their backcross lines clearly demonstrate that CYP82E4 can 
increase demethylation and decrease EFnnic.  
 
 
Figure 2.7. Changes of EFnnic and demethylation due to the mutation of nicotine 
demethylase CYP82E4. Tobacco lines were grown in the field and top leaves were 
sampled from air-cured plants. All dried samples were analyzed for alkaloid levels and 
nornicotine composition. Demethylation is calculated based on nicotine and nornicotine 
levels and EFnnic is calculated based on (R)-nornicotine and (S)-nornicotine levels. 
38 
 
Controls were the parent DH98-325-6 (P) and the commercial line TN90LC. Details of 
how the mutant lines were created are described by Lewis et al. (2010).  
 
 
2.2.4. Selectivity of other nicotine demethylases for (R)-nicotine 
Nicotine demethylation was also measured in individual tobacco plants with CYP82E4 
silenced by RNAi (Figure 2.8.). Being different from mutants, RNAi not only inhibits the 
enzyme activity of CYP82E4, but its related family members as well. Therefore, we 
would expect to see complex effects in RNAi plants. Two parent lines were chosen for 
RNAi knockdown: one has low demethylating ability (P1 L) and the other has high 
demethylating ability (P2 H). The two parents are full-sib doubled haploid burley lines. 
They share the same parents and have similar genetic background. RNAi plants were 
grown in the field in 2006, and sampled after being air-cured. Most RNAi lines from the 
low converter parent had lower demethylation and EFnnic than their parent. This 
demonstrates that in these lines demethylation is further inhibited (lower demethylation), 
and (R)-nicotine demethylation is inhibited more than (S)-nicotine demethylation (lower 
EFnnic). RNAi lines have similar demethylation but lower EFnnic than effective e4 mutants, 
suggesting that other demethylases can use (R)-nicotine more readily than (S)-nicotine. 
This could be CYP82E5, CYP82E10 or other unidentified demethylases. RNAi lines 
from the converter parent had striking differences in demethylation and EFnnic. Line P2 
RNAi #1-1 behaved like a converter, which has high demethylation and low EFnnic. Line 
P2 RNAi #1-2 behaves like a RNAi plant from the low converter parent, which had low 
demethylation and low EFnnic. Line P2 RNAi #3-2 behaved like a low converter with low 
demethylation and high EFnnic.  
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Figure 2.8. EFnnic and demethylation in different RNAi lines. All tobacco lines were 
grown and air-cured in Blackstone, VA. All dried samples were analyzed for alkaloid 
levels and nornicotine composition. Demethylation is calculated based on nicotine and 
nornicotine levels and EFnnic is calculated based on (R)-nornicotine and (S)-nornicotine 
levels. TN90 is a commercial cultivar. DH98-325-5 (P1) and DH98-325-6 (P2) are full-
sib doubled haploid burley lines, which are the parents of all other RNAi lines. Details of 
how RNAi plants were created are described by Lewis et al. (2008). 
 
 
 
2.3. Discussion 
The discrepancy between nicotine and nornicotine composition has puzzled researchers 
for a long time. It has been reported that there is a wide range of EFnnic. In this study, we 
found that 60-80% of nornicotine in root of conventional tobacco was the R form, and 5-
80% of nornicotine in leaf was the R form (Figure 2.3). These results are consistent with 
previous reports (Table1). CYP82E4 expression induction by ethephon treatment is 
correlated with elevated demethylation. Both (R)- and (S)- nornicotine accumulation is 
increased but (S)-nornicotine accumulated much more than (R)-nornicotine, which results 
in reduced EFnnic. The effects of CYP82E4 on nornicotine composition were confirmed 
by CYP82E4 mutants and their backcross to parent. There are two other functional 
nicotine demethylases in tobacco, CYP82E5v2 and CYP82E10, besides CYP82E4. RNAi 
plants which have all nicotine demethylases silenced have lower EFnnic than only the e4 
mutants, suggesting that combination of CYP82E5v2 and CYP82E10, or other 
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unidentified demethylases, have a high selectivity for (R)-nicotine.  Based on the results 
reported above, a model to explain the nornicotine composition is proposed. CYP82E5v2 
and CYP82E10 have high selectivity for (R)-nicotine, and can produce 0.80 EFnnic from 
low EFnic. CYP82E4 produced more (S)-nornicotine than (R)-nornicotine at the mature 
growth stage, resulting in a reduced EFnnic.  
 
Potentially there are several reasons responsible for the high and variable EFnnic. We 
show in this study three demethylases have significant impacts on the nornicotine 
composition, suggesting that the enantioselectivity of nicotine demethylases play a 
pivotal role in nornicotine enantiomer accumulations. These three demethylases have 
been biochemically studied. In the future, the selectivity of these three demethylases for 
nicotine enantiomers should be characterized. 
 
2.4. Conclusions 
High and variable EFnnic is found in tissues of tobacco with different demethylating 
capabilities. Experiments of induction and inhibition of CYP82E4 activity in tobacco 
demonstrate that CYP82E4 decreases EFnnic  in tobacco leaf. Results from RNAi silenced 
demethylation plants suggest that enantioselective demethylation has an important role in 
the high and variable EFnnic . 
 
2.5. MATERIALS AND METHODS 
2.5.1. Plant materials 
TN90LC represents low nicotine demethylation (low converter) plants. For several RNAi 
plants, burley tobacco breeding lines DH98-325-5 and DH98-325-6 were transformed 
with 298-bp of CYP82E4 cDNA to silence CYP82E4 and its closely related homologues. 
Based on PCR and ultra-low demethylation phenotype, R2 families of stable expressing 
the CYP82E4-silenced condition were used in this study. Details of generation and 
growth conditions of low converter and RNAi plant have been described in a previous 
paper (Lewis et al., 2008). Details of development of mutants is described in a previous 
paper (Lewis et al., 2010).  Both low converter and RNAi plants were grown at 
Spindletop farm in Lexington (KY) in 2006, and were topped and sampled at mature 
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growth stage. RM52 represents high nicotine demethylation (converter) plants which 
have high nornicotine accumulation. Converter plants were grown at Spindletop farm in 
Lexington (KY) in 2007 and were sampled at flowering stage. All the samples were 
freeze-dried and ground for further individual alkaloids content and nornicotine 
enantiomers analysis. 
 
2.5.2. Alkaloids quantification and separation of enantiomers of nicotine and 
nornicotine  
Nicotine, nornicotine, anabasine and anatabine were quantitatively analyzed by gas 
chromatography (GC) (Perkin-Elmer Autosystem XL with Prevent 
TM
) according to the 
‗LC-Protocol‘ (Jack and Bush, 2007). Alkaloids of ground tobacco samples were 
extracted by methyl tert-butyl alcohol (MTBE) and aqueous sodium hydroxide. The 
MTBE extracts was injected into GC, and quantification of alkaloids was against 
chemical standards. 
 
Nornicotine enantiomer analysis was done by extracting ground tobacco samples with 
MTBE and aqueous sodium hydroxide. Nornicotine in MTBE extract was purified by 
thin layer chromatography (TLC). TLC plates were TLC Silica Gel 60 F254 (EMD 
Chemicals Inc.). Developing solvent for TLC was chloroform: methanol: ammonia 
hydroxide (85:15:2, v/v/v). Nornicotine band was scraped from TLC plates and the TLC 
powder was directly derivatized by camphanic acid chloride solution for 30 min. The 
reaction was stopped by addition of saturated sodium carbonate solution, and the solution 
was extracted by MTBE. MTBE extracts were dried with anhydrous sodium sulfate and 
then were injected into GC (6890 Agilent GC, Agilent Technologies) for R/S nornicotine 
analysis. Samples were injected in splitless mode at 250 
o
C. The oven temperature 
program was initially 120 
o
C, increased 30 
o
C min
-1
 to 215 
o
C, then 0.2 
o
C min
-1
 to 220 
o
C held for 10 min, then 3 
o
C min
-1
 to a final temperature 300 
o
C, and held for 20 min. 
Temperature of flame ionization detector (FID) was 320 
o
C . GC column was DB1 (60 m 
(L) × 320 um (D) × 0.25 um (FT)) (J&W Scientific). The carrier gas was helium, and the 
flow was 1.7 ml min
-1
. R/S ratio of nornicotine was calculated based on peak area of each 
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isomer. Nornicotine isomer amount was calculated based on total nornicotine amount and 
R/S ratio. 
 
Enantiomer fraction (EF) (Harner et al., 2000): EF = R enantiomer / (R enantiomer + S 
enantiomer) 
 
 
Supplemental Material 
Table S2.1. Alkaloids concentrations in different tissues of four tobacco lines. 
Table S2.2. Alkaloids concentrations in ethephon-treated tobacco. 
Table S2.3. Alkaloids concentrations in e4 mutants. 
Table S2.4. Alkaloids concentrations in RNAi plants. 
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Chapter 3 Enantioselective demethylation of nicotine as a mechanism for variable 
nornicotine composition in tobacco leaf 
3.1. Introduction 
Nicotine, nornicotine, anabasine and anatabine are the four main alkaloids in tobacco 
(Nicotiana tabacum L.). Nornicotine is the product of nicotine demethylation in tobacco 
leaves. There are three functional P450 nicotine demethylases of Nicotiana tabacum L. 
reported in the literature: CYP82E4 (Siminszky et al., 2005), CYP82E5v2 (Gavilano and 
Siminszky, 2007) and CYP82E10 (Lewis et al., 2010). CYP82E4 is the major nicotine 
demethylase, and loss of function of CYP82E4 can cause up to a 95 % reduction of 
nicotine demethylation to nornicotine (Lewis et al., 2010). During maturation and curing, 
nornicotine in the leaf may be N'-nitrosated to N'-nitrosonornicotine (NNN), one of the 
major tobacco-specific N-nitrosamines (TSNAs) which has received much research 
attention because of its carcinogenicity.  
 
Different alkaloid enantiomers have different pharmacological activities. It has been 
reported that (S)-nicotine is more physiologically potent (Pogocki et al., 2007) and (S)-
NNN is more carcinogenic than the (R)- form (McIntee and Hecht, 2000). Due to the 
importance of the enantiomer composition, the enantiomers of all the four main alkaloids 
have been investigated. Of the four alkaloids, nornicotine is the only one that has a wide 
range of enantiomer fraction (EF) (Figure 3.1). Despite extensive studies, the nornicotine 
enantiomeric composition in tobacco leaf cannot be explained by current data. In tobacco 
about 0.2 % of the nicotine is the (R)-enantiomer (0.002 EF) (Armstrong et al., 1998), 
whereas nornicotine displays considerably high and variable EFnnic (0.04 to 0.75) in leaf 
(Fannin et al., 1996; Armstrong et al., 1999; Liu et al., 2008). Understanding the 
mechanisms behind the discrepancies of the enantiomeric composition between substrate 
and product will not only help to better understand the accumulation of enantiomers of 
nicotine and nornicotine in tobacco leaves, but could also provide a basis for future 
manipulation of the enantiomeric composition of nicotine, nornicotine and their 
metabolites. 
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Figure 3.1. Biosynthesis and enantiomeric composition of the four main alkaloids in 
Nicotiana tabacum L. Four major alkaloids in tobacco are boxed and only (R) form 
structure is drawn. The percentage value in the figure is from leaf samples. Enzyme E4: 
CYP82E4; E5 CYP82E5v2; E10: CYP82E10.  
 
 
The large differences between the enantiomeric composition of the precursor, nicotine, 
and the product nornicotine have puzzled researchers for half a century (Kisaki and 
Tamaki, 1961b). Racemization of nornicotine was proposed to explain the high (R)-
nornicotine accumulation (Leete, 1992), supported by the claim that (R)-nornicotine was 
observed in leaf when feeding (S)-nicotine (Kisaki and Tamaki, 1961b). However, the 
racemization was not confirmed in cell culture assay (Hao and Yeoman, 1996; Mesnard 
et al., 2001).  
 
Besides racemization, the significant differences in R/S nornicotine ratios could be 
caused by enantioselective demethylation of (R)-nicotine suggested in the assays of 
excised leaf (Kisaki and Tamaki, 1961b; Kisaki and Tamaki, 1964), whole plant (Bush et 
al., 2003) and the tobacco cell cultures (Mesnard et al., 2001). Although Leete and 
Chedekel (1974) claimed that demethylation rates of (R)- and (S)-nicotine were the same 
in a whole plant feeding assay, there was a slightly higher amount of (R)-nornicotine 
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recovered. All three demethylases have been biochemically characterized in vitro 
(Gavilano and Siminszky, 2007; Xu et al., 2007a; Lewis et al., 2010), but their 
enantioselectivity are not known. 
 
In this study, we confirmed the enantioselective demethylation and found no 
racemization during demethylation by using recombinant CYP82E4, CYP82E5v2 and 
CYP82E10 in vitro. We also showed in vitro that the cooperation of three demethylases 
could generate the enantiomeric composition of nornicotine accumulated in tobacco leaf.  
 
3.2. Results 
3.2.1. Optimization of in vitro enzyme assay of nicotine enantiomers 
Effects of protein concentration, pH and reaction time on recombinant CYP82E4 were 
studied to optimize the in vitro enzyme assay. Protein concentration did not affect 
enzyme reaction rate until it exceeded 1.0 mg ml
-1
 (Figure 3.2A). Enzyme demethylation 
had the highest activity at pH 7.5 (Figure 3.2B), which is consistent with a  previous 
report using a partially purified protein extract (Chelvarajan et al., 1993). Rate of 
nornicotine formation increased linearly for 30 min incubation at which time 95 % of 
(R)-nicotine had been demethylated to (R)-nornicotine (Figure 3.2C). Therefore, 0.5 mg 
ml
-1
 protein concentration, pH 7.5 reaction buffer and 10 min reaction time were used in 
following enzyme assays. Under conditions other than the optimum, the differences 
between (R) and (S)- nicotine demethylation were reduced.  
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Figure 3.2. Dependence of CYP82E4-catalyzed demethylation of (R)-nicotine or (S)-
nicotine on the amount of protein (A), pH (B) and reaction time (C). Microsomes 
from yeast over-expressing the CYP82E4 gene were incubated with 5µM nicotine, 
followed by extraction and quantification of (R)-nornicotine and (S)-nornicotine . 
Nicotine substrate in panel B was mainly monopotonated at the low pH and at pH 8.0 
about 1:1 monoprontonated: free base. Each data point is the average of three replicates 
and the error bar represents the standard deviation.   
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3.2.2. Enantioselectivity of CYP82E4, CYP82E5v2 and CYP82E10  
To test the enantioselectivity of CYP82E4 for nicotine, different amounts of (R)- or (S)- 
[2′-
14
C]nicotine were incubated with the enzyme preparation. Vmax for (R)-nicotine (0.55 
nmol min
-1
 mg
-1
 protein) was three-fold higher than Vmax for (S)-nicotine (0.17 nmol min
-
1
 mg
-1
 protein), and there was no significant difference between Km of (R)-nicotine and 
(S)-nicotine (Figure 3.3A). Vmax of (R)-nicotine was close to the previously reported Vmax 
using racemic nicotine as substrate (0.54 nmol min
-1 
mg
-1
 protein) (Xu et al., 2007a). 
Results from inhibition assays illustrate the competitive inhibition between the two 
nicotine enantiomers (Figure S3.1). 
 
CYP82E5v2 and CYP82E10 account for less than 5% of nicotine demethylation in plants 
accumulating high nornicotine (Lewis et al., 2010). Besides CYP82E4, enantioselectivity 
of CYP82E5v2 and CYP82E10 was also determined (Figure 3.3B and Figure 3.3C). 
Enzyme kinetics show CYP82E5v2 and CYP82E10 almost exclusively used (R)-nicotine 
over (S)-nicotine, and in both cases Vmax,R was over 10 fold higher than Vmax,S. Compared 
with Michaelis-Menten constants in the literature (Table S3.1), Km,R in this study were 
always about half of the Km in previous reports using racemic nicotine.  
 
After demethylation of either (R)- or (S)-nicotine, only the corresponding form of 
nornicotine enantiomer was detected in these assays. There was no racemization found 
during the CYP82E4-, CYP82E5v2- and CYP82E10- catalyzed demethylation.   
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Figure 3.3. Substrate preferences of CYP82E4 (A), CYP82E5v2 (B) and CYP82E10 
(C) for (R)-nicotine and (S)-nicotine. 0.5 mg ml
-1
 microsomes from yeast over-
expressing the CYP82E4, CYP82E5v2 or CYP82E10 were incubated with varying 
amount of nicotine for 10 min, followed by extraction and quantification of (R)-
nornicotine and (S)-nornicotine. Values in the parenthesis represent the standard error for 
Vmax and Km. Each data point is the average of three replicates. The error bars and data in 
the parenthesis represent the standard deviation.  
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3.2.3. Combination of the three demethylases to generate leaf nornicotine 
composition in vitro 
After demonstrating the enantioselectivity of three demethylases, the next question would 
be, can they convert a low R percentage of nicotine into the high R percentages of 
nornicotine reported in the literature. RNAi plants with all three demethylases silenced 
accumulate about 3 % (R)-nicotine of total nicotine (unpublished data). Therefore, 3% 
(R)-nicotine could be the nicotine composition at the time of synthesis and was used in 
the following assays.  
 
In tobacco plants, nicotine is stored in cell vacuoles and the P450 demethylases are 
integrated into the endoplasmic reticulum membrane facing the cytosol. Although the 
concentration of endogenous nicotine is 60 mM in the vacuoles in the leaf tip (Lochmann 
et al., 2001) and is much higher than the concentration needed for the maximum rate of 
nicotine demethylation, the actual concentration of available nicotine in cytosol for the 
demethylase enzyme is not known. Therefore, a large range of total nicotine was tested in 
vitro, and no concentration effect on nornicotine composition was measured (Figure 
S3.2A). Nicotine substrates with different R/S ratios were used in in vitro assays to 
determine the relationship between (R)-nicotine substrate and (R)-nornicotine produced 
in the presence of (S)-nicotine (Figure S3.2B). Since there was no concentration effect on 
product profile (Figure S3.2A), (R)-nicotine mixtures with variable concentrations were 
used to cover a wide range of (R/S)-nicotine ratios as substrate. Based on the results 
presented in Figure S3.2B, it would require a EFnic from 0.008 to 0.27 to obtain the 0.04 
to 0.75 of EFnnic. These values of (R)-nicotine are much higher than generally found in 
the plant and also the nicotine composition in RNAi plants, which implies the 
involvement of other demethylases. 
 
Each of the three demethylases was incubated with 3% (R)-nicotine for a time course 
study, and product compositions at different reaction time were observed for each 
demethylase (Figure 3.4 and Figure S3.3). During the 3 h reaction, less than 5% of total 
50 
 
nicotine substrate was demethylated by CYP82E5v2 and CYP82E10, and the nornicotine 
formed consisted of over 70% of (R) form, which reaches the upper limit of EFnnic found 
in tobacco plants. In contrast to CYP82E5v2 and CYP82E10, CYP82E4 demethylated 
over 30% of nicotine in 3 h reaction, and the nornicotine product consisted of 5-20% of 
(R) form, which is close to the lower limit of EFnnic found in tobacco plants. So it is 
logical to speculate that the mixture of three nicotine demethylases could potentially 
produce nornicotine with 0.04 to 0.75 EFnnic from nicotine with 0.03 EFnic. To test the 
combination effects of three demethylases on nornicotine composition, a mixture of equal 
protein amount of CYP82E5v2 and CYP82E10 was first incubated with 0.03 EFnic of 
nicotine for 30 min, and then the same protein amount of CYP82E4 was added to the 
mixture for another 2.5 h (Figure 3.4 insert). The EF of the nornicotine product 
continuously decreased, as the duration of the incubation time increased.      
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Figure 3.4. Generation of leaf nornicotine enantiomeric composition using CYP82E4 
(E4), CYP82E5v2 (E5) and CYP82E10 (E10) in vitro. Nicotine solutions (0.03 EFnic) 
were incubated with each of three demethylases separately or collectively (see insert), 
and the nornicotine enantiomeric composition was analyzed after varying time of 
incubation. This figure is a rearrangement of figure S3.3. For collective incubation, same 
amount of CYP82E5v2 and CYP82E10 were mixed and incubated with substrate, and at 
30 min equal amount of CYP82E4 was added into mixture for incubation. Total protein 
in single and collective enzyme incubation are same. Each data are average of two 
independent assays.   
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3.2.4. Substrate specificity of CYP82E4, CYP82E5v2 and CYP82E10 
A series of nicotine analogues have been shown to be used by tobacco through N-
dealkylation (Dawson, 1951; Kisaki and Tamaki, 1964; Kisaki et al., 1978; 
Bartholomeusz et al., 2005b; Robins et al., 2007) (Figure 3.5). The tobacco used in these 
reports all have high ability to demethylate nicotine. The question would be whether 
nicotine and nicotine analogues were used by the same enzymes. Methylanabasine and 
N′-ethylnornicotine, two compounds from the list (highlighted in red in Figure 3.5), were 
chosen to test substrate specificity of the three nicotine demethylases. Very low 
concentration of methylanabasine could be found tobacco leaf (Matsush et al., 1983) , 
and methylanabasine can be formed in N. tabacum and N. glauca by aberrant 
biosynthesis feeding N′-methyl-∆
1
-piperideinium choride (Leete and Chedekel, 1972).  
N′-ethylnornicotine has been found in burley tobacco (Braumann et al., 1990). Anabasine 
was formed from methylanabasine by CYP82E4, CYP82E5v2 and CYP82E10 (Figure 
S3.4), and product identity was confirmed by GC-MS. Methylanabasine and 
ethylnornicotine inhibit nicotine demethylation catalyzed by CYP82E4, CYP82E5v2 and 
CYP82E10 (Figure S3.5). So these three nicotine demethylases could potentially use a 
broad range of substrates.  
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Figure 3.5. Nicotine and nicotine analogues used by tobacco through N-dealkylation 
reaction (Dawson, 1951; Kisaki and Tamaki, 1964; Kisaki et al., 1978; Bartholomeusz et 
al., 2005b; Robins et al., 2007). Nicotine analogues were fed to tobacco leaves or cells, 
followed by the identification of N-dealkylation products. The compounds used by 
tobacco through N-dealkylation reaction are circled by red lines. (R, S)-1-methyl-2-
phenylpyrrolidine (solid borders; cut into half by the line in the table) has inconsistent 
reports. In this study, methylanabasine and ethylnornicotine were incubated with 
microsomes over-expressing three demethylase genes in vitro, highlighted by red. Details 
of the feeding assays are given in Table S1.2. Compounds with dashed border are found 
in tobacco.   
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3.3. Discussion 
The hypothesis of enantioselective demethylation was proposed to explain that the high 
and wide range of EFnnic in tobacco leaf could result from a low EFnic. In vitro all three 
nicotine demethylases CYP82E4, CYP82E5v2 and CYP82E10 demethylate (R)-nicotine 
faster than (S)-nicotine, but they exhibit different product accumulation patterns. 
Although being minor demethylases in tobacco, CYP82E5v2 and CYP82E10 have very 
strong, if not exclusively, selectivity for (R)-nicotine, and can produce 0.75 EFnnic from 
0.03 EFnic. CYP82E4 can demethylate both (R)- and (S)- nicotine, and the highest EFnnic 
produced by CYP82E4 in vitro from 0.03 EFnic of nicotine substrate is 0.20. The EFnnic 
will decrease as the CYP82E4 catalyzed demethylation proceeds. Based on the in vitro 
results, a model is proposed to explain the variable nornicotine enantiomeric composition 
(Figure 3.6). In tobacco, expression of CYP82E5v2 is constitutive, and CYP82E4 
expression is induced during senescence. So newly synthesized nicotine with a higher 
EFnic , could have the (R)-nicotine demethylated by CYP82E5v2 and CYP82E10 prior to 
activation of CYP82E4 and thus yield the higher EFnnic.  Then during senescence, 
CYP82E4 demethylates both (R) and (S)- nicotine and reduces EFnnic. Therefore, the high 
and variable EFnnic relative to EFnic can be putatively explained by the combined action of 
CYP82E4, CYP82E5v2 and CYP82E10.  
 
 
 
Figure 3.6. Proposed nicotine and nornicotine enantiomeric composition affected by 
three nicotine demethylases in tobacco leaf. The pie charts represent the relative 
abundance of (R)- and (S)- nicotine  and nornicotine. 
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In tobacco, CYP82E5v2 and CYP82E10 are dominant, but not additive (Lewis et al., 
2010). This could be explained by the observation of the enantioselectivity of 
CYP82E5v2 and CYP82E10. Since CYP82E5v2 and CYP82E10 almost exclusively use 
(R)-nicotine, and the (R) isomer only accounts for 3% of total nicotine, presence of either 
of them is enough to use that amount of (R)-nicotine. The promiscuity of CYP82E4 could 
explain the results that addition of CYP82E5v2 and CYP82E10 to plant with CYP82E4 do 
not cause an increase in nicotine demethylation. The selectivity of CYP82E4, 
CYP82E5v2 and CYP82E10 can also explain the choice of 3 % conversion in the ―LC‖ 
protocol (Jack and Bush, 2007). ―LC‖ protocol is a standard practice used by tobacco 
breeders to remove high demethylation plants during seed production to reduce 
demethylation in the progeny. Of the three nicotine demethylases, CYP82E4 is 
responsible for over 90% of the demethylation and plants with high expression of  
CYP82E4 should be excluded from seed production. Since CYP82E5v2 and CYP82E10 
can only use no more than 3% of nicotine, any plant with more than 3% demethylation 
must contain CYP82E4 expressed gene and should be excluded.  
 
In planta there may be other factors contributing to the nornicotine enantiomeric 
composition. Although nornicotine is mainly synthesized in leaf (Dawson, 1945), some 
nornicotine can also be produced in the root (Mizusaki et al., 1965) and be translocated to 
the leaf like nicotine. Translocation of nornicotine from root to leaf could influence the 
nornicotine composition in leaf. Mutant plants with all three demethylases knockout still 
contain some nornicotine, which suggests the possibility of direct synthesis of nornicotine 
other than by demethylation (Lewis et al., 2010). The report that (S)-nornicotine is 
degraded faster than (R)-nornicotine could account for some of the increased (R/S)-
nornicotine ratios and introduces another level of complexity in planta (Kisaki and 
Tamaki, 1966; Mesnard et al., 2001).  
 
Recombinant human CYP2A6, CYP2B6 and CYP2A13 expressed in baculovirus-
infected insect cells, can catalyze the demethylation of nicotine, and they all use a broad 
range of substrates (Yamanaka et al., 2005). It has been shown in tobacco cell cultures 
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and leaf feeding assays that a wide range of nicotine analogues can be used as substrate, 
through the N-dealkylation process. Methylanabasine and ethylnornicotine, two of the 
analogues used by tobacco, were shown to be the substrate of nicotine demethylase. 
Therefore, demethylation of nicotine could be one of a specific case of the general N-
dealkylation reaction catalyzed by these nicotine demethylases. 
 
(S)-nicotine is more physiologically potent than the (R)-enantiomer (Pogocki et al., 2007) 
and it is often speculated that from an evolutionary point of view nicotine is accumulated 
in tobacco to deter herbivores (Steppuhn et al., 2004). Therefore, an evolutionary 
selection could be operative for plants that produced the more potent form, (S)-nicotine 
with lower demethylation of the (S) than (R)- enantiomer. 
 
Racemization has been proposed to explain the high R/S ratios of nornicotine but 
racemization would unlikely occur during the demethylation in planta. Nicotine 
demethylation in tobacco is catalyzed by cytochrome P450 (Siminszky et al., 2005), and 
the demethylation proceeds by oxidation of N-methyl group (Mesnard et al., 2002). 
Based on N-dealkylation catalyzed by P450s (Meunier et al., 2004), it has been 
hypothesized that demethylation of (S)-nicotine yields (S)-nornicotine and that 
demethylation of (R)-nicotine yields (R)-nornicotine (Figure S3.6).  The in vitro 
experimental results in this study also indicate that racemization during demethylation is 
not a mechanism of altering the enantiomeric composition of nornicotine.  
 
Nicotine synthase has not been genetically or biochemically characterized. Until now 
only a putative enzyme mixture (Friesen and Leete, 1990) and candidate genes (A622 
gene (DeBoer et al., 2009; Kajikawa et al., 2009); berberine bride enzyme-like gene 
(Kajikawa et al., 2011)) were identified. It is general belief that nicotine biosynthesis is 
an enantiospecific process. However, selective demethylation of (R)-nicotine in vitro and 
the presence of 0.03 EFnic in RNAi silenced demethylation plants suggest that the 
originally synthesized (R)-nicotine may account for more than the reported 0.2 % of total 
nicotine.  
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Nicotiana tabacum L. (tobacco) is an allotetraploid derived from ancestors of the modern 
diploids, N. sylvestris and N. tomentosiformis. Five nicotine demethylase have been 
identified, and the functional nicotine demethylases CYP82E4 and CYP82E5v2 originate 
from N. tomentosiformis, and CYP82E10 comes from N. sylvestris (Table S3.2). 
CYP82E5v2 and CYP82E10 have higher amino acid sequence similarity and similar 
selectivity compared to CYP82E4. Therefore, CYP82E4 could be the duplication and 
mutation of CYP82E5v2. 
 
 
3.4. Conclusion 
There is high and variable enantiomer fraction of nornicotine in conventional tobacco, 
while the EFnic is always low. All three nicotine demethylases were used to test the 
hypothesis of enantioselective demethylation. In vitro recombinant demethylase 
CYP82E4, CYP82E5v2 and CYP82E10 all had a preference for (R)-nicotine substrate, 
and combined activity of these three demethylases could be the reason that cause the 
differences between nicotine and nornicotine composition in planta. No racemization was 
found during demethylation. The demethylation of nicotine could be a specific case of a 
general N-dealkylation catalyzed by CYP82E4, CYP82E5v2 and CYP82E10. In 
summary, our enzymatic studies reveal a possible role for enantioselective demethylation 
in nornicotine enantiomeric composition, by which preference of (R)-nicotine as 
substrate over (S)-enantiomer form a high enantiomer fraction of nornicotine. 
  
3.5. MATERIALS AND METHODS 
3.5.1. Expression of nicotine demethylases CYP82E4, CYP82E5v2 and CYP82E10 in 
yeast 
CYP82E4v1, CYP82E5v2 and CYP82E10 cDNA were cloned into the yeast expression 
vector pYeDP60 and transformed into yeast strain WAT11 (Siminszky et al., 2005; 
Gavilano and Siminszky, 2007; Xu et al., 2007a; Lewis et al., 2010). WAT11 is a yeast 
line engineered to enhance the expression of plant P450s through the coexpression of 
Arabidopsis P450 reductase gene (Pompon et al., 1996). Transformed WAT11 yeast cells 
were spread on synthetic galactose induction (SGI) plates. A single colony was used to 
57 
 
inoculate 10 ml SGI media and was grown with shaking at 30 
o
C for 24 h. An aliquot of 
this culture was diluted 1:50 into 250 ml of YPGE medium (10 g L
-1
 yeast extract, 20 g 
L
-1
 bacto peptone, 5 g L
-1
 glucose and 30 g L
-1
 ethanol). The culture was grown until the 
glucose was completely consumed as indicated by the Diastix urinalysis reagent strip. 
DL-galactose was added to a final concentration of 2 % (W/V) to induce production of 
the cloned gene. Cells in the culture were grown for an additional 20 h prior to the 
microsome preparations. 
 
3.5.2. Yeast microsome preparation  
Induced yeast cells were collected and used for microsome preparation (Xu et al., 2007a). 
The collected cells were washed twice with TES buffer and TES-M buffer. Then the cells 
were resuspended in extraction buffer and broken with glass beads. The cell extracts were 
centrifuged for 20 min at 20 000 g, and the supernatant was ultracentrifuged at 100 000 g 
for 90 min. The pellets containing the microsomal protein were suspended in TEG-M 
buffer. Protein concentration was determined with Bradford protein assay. 
 
3.5.3. In vitro enzyme assay 
Nicotine demethylase activity was assayed in a reaction mixture (20 µl) containing 0.5 
mg ml
-1
 microsomal protein, 2.5 mM NADPH, 25 mM Tris buffer (pH 7.5) and different 
amounts of (R)-, (S)- or racemic [2′-
14
C]nicotine.  Five µM nicotine substrate was used in 
validation assays. Recovery of nicotine and nornicotine for all three assays ranged from 
92 to 108 %. (R)- and (S)- [2′-
14
C]nicotine were separated from racemic [2′-
14
C]nicotine 
(Moravek Biochemicals and Radiochemicals). (R)- and (S)-nicotine were baseline 
separated by chiral high-performance liquid chromatography (HPLC) (Figure S3.7). (R)-
nicotine was 49.8% of the original racemic [2′-
14
C]nicotine analyzed. Nornicotine 
contamination in the [2′-
14
C]nicotine is under 0.5 %. Reaction mixtures were incubated at 
room temperature for 10 min and the reactions were stopped by addition of 20 µl 
methanol containing 50 mM nicotine and nornicotine.  
 
Nicotine demethylation was measured by resolving the nicotine and nornicotine in 10 µl 
of reaction mixture by thin layer chromatography (TLC) and 
14
C-nicotine and 
14
C-
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nornicotine were quantified by liquid scintillation counter (1900 TR, Packard Instrument 
Company). 
 
EFnnic determinations used the remaining reaction mixture of each sample to separate the 
nicotine and nornicotine by thin TLC, and the nornicotine was methylated to nicotine by 
incubating for 30 min with 50 µl formic acid and 100 µl formaldehyde at 110 
o
C. TLC 
plates were TLC Silica Gel 60 F254 (EMD Chemicals Inc.). Developing solvent for TLC 
was chloroform: methanol: ammonia hydroxide (85:15:2, v/v/v). The nicotine was base 
extracted by MTBE and collected after further separation into (R)- and (S)-enantiomer  
by chiral HPLC (Mesnard et al., 2001). A Perkin-Elmer series 200 HPLC was used with a 
Chiracel OD-H column (0.46 cm (D) × 25 cm) (Chiral Technologies Inc.) and eluted with 
hexanes/ methanol (98:2, v/v) at 1.0 ml min
-1
, with detection at 252 nm. (R) and (S) 
collections were quantified by liquid scintillation counting. The data were analyzed by 
Sigmaplot 12. Enantiomer fraction (EF) (Harner et al., 2000): EF = R enantiomer / (R 
enantiomer + S enantiomer) 
 
To test the specificity of three demethylases, methylanabasine was incubated with 
CYP82E4, CYP82E5v2 and CYP82E10 in vitro. After 10 h reaction, the incubations 
were stopped by base and extracted with MTBE containing quinoline as internal standard. 
Extracts were analyzed by GC-MS with a Varian CP-3800 GC coupled to a Varian 
Saturn 2200 MS/MS (Varian Medical Systems) using a Supelco SLB-5ms fused silica 
capillary column (30 m x 0.25 mm x 0.25 μM film thickness, Supelco). Initial oven 
temperature was set at 150 
o
C for 0.5 min, increased 15 
o
C min
-1
 to 170 
o
C, then 1.5 
o
C 
min
-1
 to 195 
o
C held for 2 min, then 20 
o
C min
-1
 to a final temperature 300 
o
C, and held 
for 20 min.  
 
 
Supplemental Material 
Table S3.1. Comparison of Michaelis-Menten constants with literatures. 
Table S3.2. Evolution of nicotine demethylases in N. tabacum L. 
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Figure S3.1. Competitive inhibition of CYP82E4-catalyzed (S)-nicotine demethylation by 
(R)-nicotine shown in Lineweaver-Burk plot.  
Figure S3.2. Inability of CYP82E4 to generate leaf nornicotine composition in vitro.  
Figure S3.3. Time course of a 10 µM 3:97 ratio of R/S-nicotine incubated with CYP82E4, 
CYP82E5v2 and CYP82E10 separately or collectively.  
Figure S3.4. Anabasine was identified in the incubations of methylanabasine with 
CYP82E4, CYP82E5v2 and CYP82E10 in vitro.  
Figure S3.5. Nicotine demethylation inhibited by methylanabasine and ethylnornicotine 
catalyzed by CYP82E4, CYP82E5v2 and CYP82E10. 
Figure S3.6. Two possible mechanisms in N-demethylation of nicotine catalyzed by 
cytochrome P450 enzymes (Meunier et al., 2004).                                                                                                                                                               
Figure S3.7. Racemic nicotine separation by chiral HPLC.   
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Chapter 4. (R)-nicotine biosynthesis, metabolism and translocation as determined in 
nicotine demethylase mutants 
4.1. Introduction 
Nicotine is the most abundant pyridine alkaloid in tobacco (Nicotiana tabacum L.), and 
has important biological functions including antiherbivore defense and smoking addiction 
(Benowitz, 2008). Nicotine biosynthesis and metabolism has been studied extensively. 
After biosynthesis in the tobacco root (Dawson, 1942), nicotine is translocated to the leaf 
via the xylem (Guthrie et al., 1962) and stored in the leaf vacuole with the help of a 
tonoplast localized transporter (Shitan et al., 2009). Nornicotine is the major metabolite 
of nicotine in tobacco, through nicotine demethylation process. Nicotine can be 
demethylated in both leaf (Dawson, 1945) and root (Mizusaki et al., 1965), but mainly in 
aging leaf (Chakrabarti et al., 2008). During curing, four main alkaloids of tobacco, 
nicotine, nornicotine, anabasine and anatabine, may be nitrosated to N′-nitrosonornicotine 
(NNN), 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), N′-nitrosoanatabine 
(NAT), N′-nitrosoanabasine (NAB), respectively. NNK and NNN are two of the most 
abundant and carcinogenic of the seven tobacco-specific nitrosamines (TSNAs) identified 
in tobacco products (Hecht, 1998). Nicotine synthase has not been genetically or 
biochemically characterized. Until now only a putative enzyme mixture (Friesen and 
Leete, 1990) and candidate genes (A622 gene (DeBoer et al., 2009; Kajikawa et al., 
2009); berberine bride enzyme-like gene (Kajikawa et al., 2011)) were identified. Three 
functional nicotine demethylases in tobacco have been reported: CYP82E4 (accounts for 
most demethylation in senescing leaf), CYP82E5v2 and CYP82E10 (Siminszky et al., 
2005; Gavilano and Siminszky, 2007; Xu et al., 2007a; Lewis et al., 2010).  
 
Nicotine has two enantiomers which differ from each other at 2'-C position on pyrrolidine 
ring. (S)-nicotine is predominant form, and (R)-nicotine only accounts for 0.2% of total 
nicotine in cured leaf (Armstrong et al., 1998). Therefore, nicotine is considered to be 
equal to (S)-nicotine in most literature. Unless stated, enantiomer fraction (EF) in the 
following context represents (R)-enantiomer proportion of total given compound. The 
reports for nornicotine enantiomeric composition are inconsistent, EF of nornicotine 
ranging from 0.04 to 0.75 (Armstrong et al., 1999; Liu et al., 2008). It is puzzling how 
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0.002 of EFnic results in nornicotine with 0.04-0.75 EF in tobacco leaf (Figure 4.1). Our 
previous characterization of nicotine demethylases in vitro suggests a higher EFnic and 
selective demethylation of (R)-nicotine. Selective demethylation of nicotine was reported 
when feeding excised tobacco leaf (Kisaki and Tamaki, 1964) and tobacco cell culture 
(Mesnard et al., 2001). The questions then become how much (R)-nicotine is 
biosynthesized in tobacco root, and how is it demethylated in root and leaf. 
 
 
 
Figure 4.1. The puzzle of the discrepancy between nicotine and nornicotine 
enantiomeric composition. Enantiomer fraction (EF) represents the percentage of R 
enantiomer. (S)-nicotine accumulates to greater than 99% of the total nicotine content in 
leaves, yet nornicotine accumulates predominately in the R configuration. Is this because 
the enzyme(s) responsible for demethylation of nicotine possess sufficient specificity for 
(R)-nicotine, rather than (S)-nicotine? 
 
 
 
Enantiomers of nicotine and nornicotine-nitrosated product NNN behave differently in 
animal models and human. The LD50S for intravenous administration of (R)-nicotine in 
several animal species is approximately 18-times higher than that of (S)-nicotine 
(Pogocki et al., 2007). A significantly lower level of toxic and carcinogenic metabolites is 
produced from (R)-nicotine. Based on the overall cytotoxicity of the compound and its 
metabolites, (R)-nicotine is approximately eighty times less cytotoxic than (S)-nicotine 
(Yildiz et al., 1998). (S)-NNN undergoes significantly more 2-hydroxylation than (R)-
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NNN in cultured rat esophagus and in vivo in rats. In rats treated with racemic NNN, 66% 
of 2-hydroxylation metabolites are from (S)-NNN, while 74% of the 5-hydroxylation 
products are produced from (R)-NNN (McIntee and Hecht, 2000). 2-hydroxylation of 
NNN is the major metabolic activation pathway, suggesting carcinogenicity of (S)-NNN 
may be greater than that of (R)-NNN. Understanding the mechanisms behind the nicotine 
and nornicotine composition will facilitate the future manipulation of enantiomeric 
composition of nicotine and NNN. 
 
In this paper, we confirmed the enantioselectivity of three demethylases in vivo by 
investigating nicotine demethylase mutants at different growth and leaf curing stages. 
Since nicotine metabolism can occur in root and leaf, scion/stock grafts were used to 
dissect individual leaf and root contributions to the final nicotine and nornicotine 
composition in leaf. 
 
4.2. Results 
4.2.1. Effects of nicotine demethylases on enantiomeric composition of nicotine, 
nornicotine, and TSNAs level in air-cured leaf lamina  
Previously, we have shown in vitro three nicotine demethylases had different selectivities 
for nicotine enantiomers. In this study, we wanted to determine the effects of nicotine 
demethylases in vivo. Three nicotine demethylase mutant and mutant combinations 
(Lewis et al., 2010) were grown in the field in 2010, and the air-cured leaf were analyzed 
for alkaloid level and nicotine and nornicotine enantiomeric composition. The experiment 
was repeated in 2011, adding the widely used commercial line TN90LC (Figure 4.2, 
Figure S4.1 and Table S4.1). TN90LC is widely used commercial variety and was used 
as control. 
 
With all three demethylases silenced (e4e5e10), 3% of nicotine accumulated is R 
enantiomer (0.03 EFnic). Any of three demethylases can reduce EFnic to under 0.002. Only 
CYP82E4 can significantly convert (S)-nicotine to (S)-nornicotine. CYP82E4 is the 
major demethylase and accounts for over 90 % of the demethylation in high 
demethylation plants. CYP82E5v2 and CYP82E10 are minor demethylases in tobacco, 
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probably due to the selectivity for (R)-nicotine and limitation of (R)-nicotine as substrate. 
All these results were consistent with the selectivity of three demethylases in vitro. 
 
TSNAs in mutant air-cured leaf lamina from two years field trials were also measured 
(Figure 4.2.C and Figure S4.1). NNN level was closely correlated with nornicotine level, 
while 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) was correlated with 
nicotine level. CYP82E4 changed the nicotine and nornicotine ratio in cured leaf, and 
dramatically affected NNN and NNK levels. No consistent conclusions, none were 
expected, could be drawn for the effects of demethylases on N′-nitrosoanatabine (NAT) 
and N′-nitrosoanabasine (NAB) level. Total TSNAs was inversely correlated with 
CYP82E4 activity. Without functional CYP82E4, tobacco had significantly reduced 
TSNAs. The triple mutant had lowest NNN among all the tobacco lines, but the total 
TSNAs in triple mutant was not significantly different from mutant with inactive 
CYP82E4. TN90LC in this study had similar level of individual and total TSNAs, 
compared to a previous report (Lewis et al., 2008).  
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Figure 4.2. Effects of nicotine demethylases on nicotine, nornicotine and NNN in air-
cured leaf laminas in 2010 and 2011. (A) Changes of enantiomers levels of nicotine and 
nornicotine in nicotine demethylase mutants. (B) Effects of nicotine demethylases on 
nicotine and nornicotine composition. (C) Effects of nicotine demethylases on NNN 
levels. TN90LC data is from 2011 only. Each bar is the average of two years results. The 
error bars represent standard deviation. +/- below the bars indicate the presence/absence 
of a functional demethylase gene. Demethylation reflects how much nicotine goes 
through the demethylation process. Demethylation (%) = nornicotine concentration (mg 
g
-1
) *100/ sum of nicotine and nornicotine concentration (mg g
-1
).  
 
 
 
4.2.2. Accumulation of alkaloids in mutants leaf laminas during the growth and 
curing  
During tobacco production, levels of alkaloids significantly change at two stages, apical 
decapitation and harvest. Apical decapitation, typical practice in tobacco production, 
stimulates the alkaloid production. Since CYP82E4 gene expression is induced in 
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senescing leaf, nornicotine levels increase during first two weeks of curing at the expense 
of nicotine. After confirming the selectivity of three demethylases in cured leaf, we 
wanted to know how nicotine and nornicotine enantiomers changed during growth, and to 
better understand the function of the three demethylases.  
 
Nine tobacco lines were chosen to be grown in the field in 2011, and were sampled at 
five different sampling times during growth and air-curing process. Individual alkaloids 
levels were determined (Figure 4.3) at five critical times during tobacco production: after 
recovery from transplant shock (one month after transplant), apical decapitation (two 
months after transplant), harvest (three months after transplant), two weeks after harvest 
and cured leaf (Figure S4.4).  
 
After apical decapitation alkaloid accumulation dramatically increased, as expected 
(Figure 4.3). During the two weeks of curing, nornicotine concentration increased 
significantly at expense of nicotine due to CYP82E4 activity. Nicotine demethylase 
mutations had no obvious effect on anabasine and anatabine accumulation, although 
nicotinic acid is shared in the biosynthesis of the four main alkaloids. Due to changes in 
nicotine and nornicotine levels, alkaloid profiles were changed in tobacco with active 
CYP82E4. For example, the parent tobacco plant (E4E5E10) had alkaloids level at one 
month after transplant nicotine > anatabine > nornicotine > anabasine; at apical 
decapitation nicotine > nornicotine > anatabine > anabasine; and during harvest and 
curing nornicotine > nicotine > anatabine > anabasine. 
 
66 
 
 
 
Figure 4.3. Leaf lamina alkaloids profile of different nicotine demethylase mutants 
during growth and curing. TN90LC (commercial variety, control) and different 
nicotine demethylase mutants were grown in the field and sampled five times. The 
sequential sampling time for each line were one month after transplant, apical 
decapitation, harvest, 2 weeks of curing and cured. Each data point is average of four 
bulk samples, and each bulk sample is a mixture of five middle leaves from five plants. 
The error bars represent standard deviation. +/- below the bars indicate the 
presence/absence of a functional demethylase gene. 
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4.2.3. Accumulation of nicotine and nornicotine enantiomers in mutant leaf lamina 
during growth and curing 
Enantiomers levels (Figure 4.4) and EF (Figure 4.5) of nicotine and nornicotine were 
analyzed at five sampling times. (R)-nicotine levels were low throughout growth and 
curing in plants with active CYP82E5 or CYP82E10. The triple mutant had much higher 
sum of (R)-nicotine plus (R)-nornicotine than that of plants without active CYP82E4 
(TN90LC, e4E5E10, e4e5E10 and e4E5e10), indicating the loss of R form. Nornicotine 
has been shown to be degraded in excised leaves (Kisaki and Tamaki, 1966). Tobacco 
with active CYP82E4 had a different accumulation pattern of (R)-nornicotine from that 
of tobacco without active CYP82E4, and continued to accumulate (R)-nornicotine after 
harvest. (S)-nicotine demethylation occurred only in tobacco with active CYP82E4 at 
harvest.  
 
Enantiomer fraction of nicotine and nornicotine changed during sampling period (Figure 
4.5). EFnic of all mutants had decreased trends at all sampling times. In the triple mutant, 
there was only a small decrease of EFnic, staying around 0.04. The mutants with inactive 
CYP82E4 had relative stable nornicotine enantiomeric composition, while plants with 
active CYP82E4 had a continuous decrease in EFnnic, due to the larger increase in the (S)-
nornicotine.  
 
The field results from 2010 and 2011 were rearranged for analyzing the relationship 
between nicotine demethylation and nornicotine enantiomeric composition (Figure 4.6). 
With only CYP82E5 or CYP82E10 active (e4E5e10 or e4e5E10), plants contained 0.50 
to 0.80 EFnnic and demethylation in these mutants was low. When only CYP82E4 was 
active (E4e5e10), the demethylation resulted in a much wider range of EFnnic, 0.06 to 
0.25. These results are consistent with in vitro enzyme assays using 0.03 EFnic (Chapter 3). 
Triple mutant had consistently very low demethylation and 0.10 to 0.25 EFnnic. When 
more than one demethylase was present (Figure 4.6 insert), EFnnic spanned 0.06 to 0.80, 
which is consistent with the wide range and high EFnnic in literature reports.   
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Figure 4.4. Accumulation of nicotine and nornicotine enantiomers in leaf lamina of 
different nicotine demethylase mutants during growth and curing. TN90LC 
(commercial variety, control) and different nicotine demethylase mutants were grown in 
the field and sampled five times. The sequential sampling time for each line were one 
month after transplant, apical decapitation, harvest, 2 weeks of curing and cured. Each 
data point is average of four bulk samples, and each bulk sample is a mixture of five 
middle leaves from five plants. The error bars represent standard deviation. +/- below the 
bars indicate the presence/absence of a functional demethylase gene. 
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Figure 4.5. Nicotine (A) and nornicotine (B) enantiomeric composition of different 
nicotine demethylase mutant leaf lamina during growth and curing. TN90LC 
(commercial variety, control) and different nicotine demethylase mutants were grown in 
the field and sampled five times. The sequential sampling time for each line were one 
month after transplant, apical decapitation, harvest, 2 weeks of curing and cured. Each 
data point is average of four bulk samples, and each bulk sample is a mixture of five 
middle leaves from five plants. The error bars represent standard deviation. +/- below the 
bars indicate the presence/absence of a functional demethylase gene.  
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Figure 4.6. Relationships between nicotine demethylation and nornicotine 
enantiomeric composition from leaf lamina of demethylase mutants during growth 
and curing. This figure combines results of 2010 cured samples and 2011 growth and 
cured samples. Each data point is the average of three or four samples. 
 
 
  
4.2.4. Contributions of three nicotine demethylases in root and leaf to the leaf 
nicotine and nornicotine composition 
Root is the site of nicotine biosynthesis and the first place of nornicotine formation. 
Kisaki and Tamaki (1960) found that in root nicotine was predominantly the S 
enantiomer, while nornicotine was predominantly the R enantiomer. After investigating 
the nicotine and nornicotine enantiomer accumulation in leaf from green field plants, we 
tried to further understand the nicotine and nornicotine enantiomeric composition in root, 
and how it affected nicotine and nornicotine composition in the leaf. Scion/stock grafts 
were used to separate the effects of root and leaf on final nicotine and nornicotine 
composition in leaf (Figure 4.7 to Figure 4.9). 
 
Tobacco plants were self-grafted to check the graft effects on nicotine and nornicotine 
composition (Figure 4.7). There was no difference between grafted and intact tobacco 
plant in terms of nicotine and nornicotine enantiomeric composition (intact plants results 
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not shown). For grafted plants, leaf, ethephon-treated leaf and root were analyzed. 
Ethephon treatment was used to enhance the aging effects after harvest. Compared to the 
results from field plants, nicotine and nornicotine composition in leaf laminas of grafted 
mutants was consistent with the enantiomeric composition in the field from apical 
decapitation and harvest stage. Also, after ethephon treatment grafted mutants had similar 
nicotine and nornicotine composition as field mutants during first two weeks of curing. 
Since leaf results are consistent with the results from the field, we further examined the 
nicotine and nornicotine compositions in root. The mutant with only CYP82E4 active 
(E4e5e10) had the same nicotine and nornicotine enantiomeric composition as e4e5e10, 
suggesting that CYP82E4 had few effects on root nicotine and nornicotine enantiomeric 
composition. Mutants with active CYP82E5v2 or CYP82E10 significantly reduced EFnic 
and had predominantly (R)-nornicotine. With all three demethylases active, roots had 
similar nicotine and nornicotine enantiomeric composition as mutants with only 
CYP82E5v2 or CYP82E10 active, indicating that in root, CYP82E5v2 and CYP82E10 
are major factors affecting nicotine and nornicotine enantiomeric composition. Except for 
triple mutants, lower EFnic was found in leaves than in roots, suggesting that all 
demethylases actively influence nicotine enantiomeric composition in leaf. 
 
Since the nornicotine in leaf is from leaf and root, tomato scions were grafted onto 
mutant roots to investigate the nicotine and nornicotine enantiomeric composition 
translocated to leaf (Figure 4.8). Tomato can produce small amount of nicotine (Sheen, 
1988), but the amount of nicotine in tomato leaf was <1% of total nicotine translocated 
from tobacco root. No demethylase activity was measured when nicotine was fed to 
tomato leaves (data not shown). The same nicotine enantiomeric composition was found 
in both tomato leaves and tobacco roots, demonstrating that nicotine enantiomeric 
composition in root reflected the nicotine composition translocated to leaf and no 
selective translocation of nicotine occurs. Consistently lower EFnnic was found in tomato 
leaves. EFnic of leaf lamina from tomato/tobacco grafts compared to self-grafted tobacco 
indicates that over 75% of the (R)-nicotine was demethylated in root, and the remainder 
was demethylated in leaf.  
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To investigate the function of three demethylases in leaf, tobacco was grafted onto triple 
mutant (e4e5e10) stock (Figure 4.9). Consequently, the same enantiomeric composition 
of nicotine (0.03-0.04 EFnic) and nornicotine (0.10-0.25 EFnnic) were supplied to mutant 
leaves via translocation. In leaf, CYP82E5v2 and CYP82E10 converted 0.03 EFnic into 
0.80 EFnnic, while CYP82E4 produced 0.15 EFnnic. These results are consistent with in 
vitro assays of selectivity of single demethylase.  
 
  
Figure 4.7. Demethylation, nicotine and nornicotine enantiomeric composition in 
self-grafted mutant tissues. The grafts do not influence the nicotine and nornicotine 
composition. Eth leaf: ethephon treated leaves which induce senescence and expression 
of CYP82E4.  Data are an average of three plants. The error bars represent standard 
deviation.  
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Figure 4.8. Nicotine and nornicotine composition in tomato/tobacco grafts. Each bar 
is an average of three replicates. The error bars represent standard deviation.  
 
 
  
Figure 4.9. Nicotine and nornicotine enantiomeric composition in tobacco/e4e5e10 
grafts. Each bar is an average of two replicates, except that root of e4E5e10/e4e5e10 
only has one replicate. The error bars represent standard deviation. 
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4.3. Discussion 
Previous studies of nicotine and nornicotine enantiomeric composition used cured leaf or 
qualitatively analytical methods. Quantitative study of nicotine and nornicotine 
enantiomeric composition during growth is lacking. In this study, alkaloid accumulation 
and enantiomeric composition of nicotine and nornicotine in different nicotine 
demethylase mutants were investigated during growth and curing. The discrepancy 
between nicotine and nornicotine enantiomeric composition was confirmed (Figure 
4.10A). Previously we have shown that in vitro three demethylases had different 
selectivity for (R)-nicotine (Figure 4.10B). Both CYP82E5v2 and CYP82E10 can convert 
0.04 EFnic into over 0.80 EFnnic, which is the reason why high EFnnic is found in some 
tobacco samples. CYP82E4 can only produce about 0.25 EFnnic from the same 0.04 EFnic. 
However, CYP82E4 expression is induced during senescence, and may demethylate 
almost all the (R)- and (S)- nicotine present in the leaf. Combination of the three 
demethylases could produce 0.04 to 0.75 EFnnic from 0.03 EFnic.  In this study, we 
confirmed the in vitro observation by using nicotine demethylase mutants (Figure 4.6).  
 
Based on the mutant graft results, we propose a model to explain the nicotine and 
nornicotine enantiomeric composition in the tobacco plant (Figure 4.10C). In triple 
mutant root (e4e5e10), synthesized nicotine consists of 4% of R form (0.04 EFnic). 
CYP82E5v2 and CYP82E10 predominately determine the nicotine and nornicotine 
enantiomeric composition in roots whereas CYP82E4 has little impact. Soon after being 
synthesized, 0.04 EFnic is reduced 0.01 EFnic, resulting in 0.60 EFnnic. Based on the EFnic 
changes, over three fourths of (R)-nicotine is demethylated in root. After that, nicotine 
and nornicotine will be translocated to leaf, where the rest of (R)-nicotine is demethylated 
by all three demethylases. CYP82E4 expression is induced dramatically during 
senescence, and (S)-nicotine is largely demethylated by CYP82E4 into (S)-nornicotine 
due to the limiting amount of (R)-nicotine present. Depending on CYP82E4 expression 
(intensity and time), a range of EFnnic was measured due to the large amount of (S)-
nornicotine production, which explains the wide range of EFnnic found in tobacco leaf. 
The general conclusion is that nicotine in tobacco consists of 4% (R)-enantiomer and 
may become essentially pure (S)-nicotine due to the selective demethylation of (R)-
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nicotine. High selectivity of CYP82E5v2 and CYP82E10 for (R)-nicotine is the reason 
that there is 0.75 EFnnic present in some tobacco leaf. Different CYP82E4 expression in 
the leaf and subsequent demethylation of (S)-nicotine to (S)-nornicotine results in a broad 
range of EFnnic. 
 
  
 
 
 
 
Figure 4.10. Effects of three nicotine demethylases on the enantiomeric composition 
of nicotine and nornicotine in high demethylation tobacco (Nicotiana tabacum L.). 
(A) Accumulation and composition of nicotine and nornicotine in converter leaf lamina 
during growth and curing in 2011 field. (B) Enantioselectivity of three nicotine 
demethylases based on in vitro enzyme assay. (C) Schematic diagram showing nicotine 
demethylases contribution on nicotine and nornicotine composition of converter leaf. 
When being synthesized (-E4 -E5 -E10) in root, EFnic is 0.04. The small amount of 
nornicotine could be the leakage of E4, based on the nornicotine composition. Soon after 
synthesis, (R)-nicotine is selectively demethylated into (R)-nornicotine, resulting in 0.60 
EFnnic from 0.04 EFnic. Over three fourths of (R)-nicotine is selectively degraded in the 
root, and the rest is translocated to the leaf, where it is demethylated. CYP82E4 
expression is mainly in leaf, especially during senescence, and has little effect on the 
nicotine enantiomeric composition in root. Depending on CYP82E4 expression, 0.04 to 
0.60 EFnnic is accumulated in leaf. 
A 
B 
C 
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The effects of CYP82E5v2 and CYP82E10 gene activity appeared to be dominant, rather 
than additive (Lewis et al., 2010). We suggest that this was due to the selectivity of these 
two enzymes based on in vitro assays. In this study, we have shown CYP82E5v2 or 
CYP82E10 alone could demethylate all (R)-nicotine by harvest time (Figure 4.4). 
Therefore, the limit of (R)-nicotine substrate and selectivity of the two demethylases are 
the reasons that CYP82E5v2 and CYP82E10 show a dominant effect. Substrate limitation 
may also be the reason why CYP82E5v2 and CYP82E10 are the minor demethylases in 
tobacco plants.    
 
There is a change in the nicotine and nornicotine profile in tobacco over evolutionary 
time (Figure 4.11). Cultivated tobacco (N. tabacum L.) is an allotetraploid species 
derived from the hybridization of ancestral N. tomentosiformis and N. sylvestris 
(Clarkson et al., 2005). Both parents have high nicotine demethylating ability, so tobacco 
must also have high demethylating ability initially. However, few of tobacco lines used 
today have strong nicotine demethylating ability as in both parents. This change is 
proposed due to the selection for high nicotine content by humans (Chakrabarti et al., 
2007). Because nornicotine is not desirable for smoking and harmful products may form 
from nornicotine, researchers are trying to reduce nornicotine through blocking the 
nicotine demethylation process (Lewis et al., 2008; Lewis et al., 2010). As the nicotine 
demethylase mutant trait is incorporated into commercial tobacco varieties (Li et al., 
2011b), we will see another significant change in the nicotine and nornicotine 
composition, this time driven by selection for low nornicotine.  
 
CYP82E10 was identified from root-specific cDNA libraries (Lewis et al., 2010), and not 
found during characterization of CYP82E genes expressed in leaf tissue (Siminszky et al., 
2005; Gavilano et al., 2007; Xu et al., 2007a), suggesting CYP82E10 expresses only in 
root. However, the graft e4e5E10/ e4e5e10 in this study (Figure 4.9) clearly shows the 
functionality of CYP82E10 in leaf.  
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Figure 4.11. Evolution of nicotine and nornicotine enantiomeric composition in 
tobacco leaf, driven by human selections. All the results are from field tobacco leaf in 
2011.  
 
 
In this study, we also found that (R)-nornicotine accumulation increased dramatically in 
mutants with active CYP82E4 during the first two weeks of curing. Since CYP82E4 
expression reached maximum at that time period, and CYP82E4 can use a broad array of 
substrates (chapter 3) demonstrated in vitro assays, we propose that the (R)-nornicotine 
spike observed 2 weeks after harvest could come from nornicotine derivatives catalyzed 
by CYP82E4 through N-dealkylation reactions. The nornicotine derivatives could come 
(E4E5E10)
(e4E5E10)
(e4e5e10)
Past
Present
Future
Selection for 
high nicotine
Selection for low 
nornicotine
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from (R)-nornicotine derivatization, or alternatively de novo biosynthesis. One piece of 
evidence to support this is that plants with active CYP82E5v2 or CYP82E10 have lower 
total R form of nicotine and nornicotine than that in e4e5e10, implying the (R)-
nornicotine is further metabolized (Figure S4.2). Those metabolites of (R)-nornicotine 
could be the source which is converted back to (R)-nornicotine.    
 
 
4.4. Conclusion 
Enantioselectivity of three nicotine demethylases has been confirmed by investigating 
nicotine and nornicotine enantiomeric composition in mutant plants during growth and 
curing. Based on mutants and graft studies, enantioselectivity of three demethylases is 
enough to explain the discrepancies between nicotine and nornicotine enantiomeric 
composition in tobacco leaf. Nicotine consists of 4% of R form when being synthesized 
in root. Nicotine demethylases CYP82E5v2 and CYP82E10 selectively demethylate (R)-
nicotine to (R)-nornicotine, resulting in 0.01 EFnic and 0.75 EFnnic, while CYP82E4 
decreases EFnnic due to the higher selectivity for (S)-nicotine than the other two 
demethylases. Most of (R)-nicotine is demethylated in root, and the rest is degraded in 
leaf. In leaf, CYP82E5v2 and CYP82E10 will still selectively use (R)-nicotine as in root, 
which keeps EFnnic high, but depending on CYP82E4 activity during senescence, 0.04 to 
0.60 EFnnic will be produced. Although nicotine demethylases have no effect on 
accumulation of the other two main tobacco alkaloids, anabasine and anatabine, they 
change the alkaloid profiles in tobacco, due to the changes in nicotine and nornicotine 
levels. 
 
4.5. MATERIALS AND METHODS 
4.5.1. Plant materials 
TN90LC is low demethylating line and widely used in commercial burley tobacco 
production. Burley tobacco breeding lines DH98-325-6 was used as parent for developing 
CYP82E4, CYP82E5 and CYP82E10 mutants. Development of these mutants is described 
previously  (Lewis et al., 2010) and a scheme for their selection is in Figure S4.3.  
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4.5.2. Mutants grown in the field 
To test nicotine demethylase selectivity, DH98-325-6 parent and seven mutants were 
grown in the field in North Carolina in 2010. To study the nicotine and nornicotine 
enantiomer accumulation, TN90LC, DH98-325-6 parent and seven mutants were grown 
at Spindletop Farm in Lexington (KY) in 2011. Each line or variety had 18 plants per 
replicate with four replicates. The arrangement of plants was in a randomized block 
design. The seedlings were grown in greenhouse at Spindletop Farm, and transplanted to 
the field (Google map location: 38.114925,-84.493119) on June 1
st
, 2011. Plants were 
sampled five times: one month after transplant (Jul. 5
th
), apical decapitation (Aug. 2
rd
), 
harvest (Aug. 31
st
), after 2 weeks of curing (Sep.15
th
) and cured (Nov.11
st
) (Figure S4.4). 
Plants were harvested and hung on a wagon in a curing barn to facilitate the sampling. 
Temperature and relative humidity were monitored during curing (Figure S4.5). Five 
middle leaf laminas (leaves without midrib) from five plants were sampled for each 
replicate per tobacco line and bulked. Some plants had been sampled at more than one 
sample time due to the shortage of plants. All the samples were oven-dried (55 
o
C), and 
ground to pass a 1 mm sieve for alkaloids and R/S enantiomer analysis. 
 
4.5.3. Graft study 
Tobacco lines used for grafting were: parent, three double mutants (E4e5e10, e4E5e10 
and e4e5E10) and triple mutant (e4e5e10). Tomato variety Rutgers was used for 
tomato/tobacco grafts (Jeffrey and Tso, 1964). Cleft grafting was used instead of 
approach grafting, which may cause the alkaloids contamination in the shoot. The grafts 
were shaded in high humidity environment for two weeks to recover. After four new 
leaves emerged, the plants were topped to induce nicotine production. Two tobacco 
leaves were sampled from each graft after two weeks of apical decapitation. One leaf was 
directly oven-dried, and the other was treated with ethephon for 2 days to induce nicotine 
demethylation before oven-drying. The roots were washed with water to remove potting 
medium, and then oven-dried. 
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4.5.4. Alkaloids quantification and separation of enantiomers of nicotine and 
nornicotine  
Nicotine, nornicotine, anabasine and anatabine were quantitatively analyzed by gas 
chromatography (GC) (Perkin-Elmer Autosystem XL with Prevent TM) according to the 
‗LC-Protocol‘ (Jack and Bush, 2007). Alkaloids of ground tobacco samples were 
extracted by methyl tert-butyl alcohol (MTBE) and aqueous sodium hydroxide. The 
MTBE extracts was injected into GC, and quantification of alkaloids was against 
alkaloids standards. 
 
Nicotine and nornicotine isomers were analyzed by chiral high-performance liquid 
chromatography (HPLC) (Mesnard et al., 2001). Ground tobacco leaves were extracted 
by MTBE and aqueous sodium hydroxide. Alkaloids from MTBE extract were dissolved 
into acid solution, and cleaned by MTBE wash to remove chlorophyll. The cleaned acid 
solution was neutralized by base and extract with MTBE. Nicotine and nornicotine from 
the MTBE extracts was purified by thin layer chromatography (TLC). Myosmine is the 
main metabolite of nornicotine and has no effects on enantiomer composition analysis of 
nicotine and nornicotine. TLC plates were TLC Silica Gel 60 F254 (EMD Chemicals 
Inc.). Purified nicotine was further separated into (R) and (S) form by HPLC (Perkin-
Elmer series 200) using a Chiracel OD-H column (0.46 cm (D) × 25 cm) (Chiral 
Technologies Inc.), eluted with hexanes/ methanol (98:2, v/v) at 1.0 ml min
-1
, with 
detection at 252 nm. Nornicotine was methylated to nicotine by incubating for 30 min 
with 50 µl formic acid and 100 µl formaldehyde at 110℃.  Enantiomer fraction of 
nicotine or nornicotine ratio was calculated by peak area of the two isomers. Nicotine and 
nornicotine isomer amount was calculated based on total nornicotine amount and R/S 
ratio. Data were analyzed by Sigmaplot 12.  
 
Enantiomer fraction (EF) (Harner et al., 2000): EF = R enantiomer / (R enantiomer + S 
enantiomer) 
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Figure S4.3. Selection of EMS-induced mutants in nicotine demethylase genes (Lewis et 
al., 2010). 
Figure S4.4. Production cycle of tobacco in 2011.  
Figure S4.5. Temperature and relative humidity during curing.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Bin Cai 2012  
82 
 
Chapter 5 Concluding remarks 
5.1. Combining the activities of CYP82E4, CYP82E5v2 and CYP82E10 is enough to 
explain the enantiomeric discrepancy between nicotine and nornicotine 
There are several possible reasons which can account for the discrepancy of enantiomeric 
composition between nicotine and nornicotine. In chapter 2, I demonstrated that nicotine 
enantioselective demethylation has an important role in the enantiomeric composition of 
nornicotine. In the following two chapters, I establish that in vitro and in vivo the 
combination of the three demethylases can produce the range of EFnnic measured in 
tobacco.  
 
During the effort to study the enantioselective demethylation, other possible reasons 
could be inferred. In chapter 3, no racemization was found in vitro during demethylation. 
In chapter 4, the same nicotine enantiomeric composition was found in tomato leaf and 
tobacco root in tomato/ tobacco grafts, suggesting there is no enantioselective 
translocation of nicotine. In chapter 2, roots of different tobacco lines have similar 
nornicotine enantiomeric composition with their stalk, suggesting there is no 
enantioselective translocation of nornicotine. Therefore, translocation is unlikely a reason 
for the discrepancy. The roles of direct synthesis and enantiomeric degradation of 
nornicotine have not been explored in this study.  
 
5.2. Lessons from enantioselective demethylation study 
5.2.1 Nicotine composition 
Leaf nicotine is reported to consist of only 0.002 EFnic, and (S)-nicotine is equal to 
nicotine in most literature. In chapter 4, I measure EFnic of 0.04 in triple mutants, 
suggesting the nicotine has much higher (R)-nicotine when biosynthesized in the root. 
The reason that only the (S)-form is found in the leaf is that (R)-nicotine is selectively 
demethylated soon after biosynthesis.     
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5.2.2. Demethylation location of nicotine enantiomers 
Two nicotine enantiomers are demethylated in different tissues. Compared with nicotine 
enantiomeric composition in tomato/tobacco grafts (Chapter 4), over 75 % of (R)-
nicotine is demethylated in root, while almost all (S)-nicotine is demethylated in leaf.   
 
5.2.3. Lack of additive effects for CYP82E5v2 and CYP82E10 
 CYP82E5v2 and CYP82E10 are two minor nicotine demethylases in tobacco. Lewis 
(2011) reported lack of additive effects for these demethylases. In chapter 3, I establish 
that CYP82E5v2 and CYP82E10 have high selectivity for (R)-nicotine. In chapter 4, I 
demonstrate that CYP82E5v2 or CYP82E10 alone could use all the (R)-nicotine in 
tobacco. Therefore, it is the (R)-nicotine substrate limitation that causes the additive 
effect to be apparently missing.   
 
5.2.4. Prediction of future changes of nicotine and nornicotine composition 
From an evolutionary standpoint, modern tobacco initially accumulated nornicotine as 
main alkaloid based on the alkaloid composition of its two progenitors. It is believed due 
to the selection of high nicotine that resulted in the tobacco accumulating more nicotine. 
Due to the undesirable properties of nornicotine, researchers are trying to incorporate the 
demethylation mutant trait into tobacco commercial lines. Therefore, in the future the 
enantiomeric composition of nicotine and nornicotine in tobacco will change due to the 
present selection for lower nornicotine.  
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Appendix 
Table S1.1. Pyridine alkaloids and its derivatives in tobacco plants (Nicotiana L.). 
Name CID* Structure Material References 
Nicotine 942 
 
Leaf of N. 
tabacum 
(Tso and 
Jeffrey, 
1953) 
Nornicotine 412 
 
Leaf of N. 
tabacum 
(Tso and 
Jeffrey, 
1953) 
Anabasine 2181 
 
Leaf of N. 
tabacum 
(Tso and 
Jeffrey, 
1953) 
Anatabine 261474 
 
Leaf of N. 
tabacum 
(Tso and 
Jeffrey, 
1953) 
Oxynicotine 409 
 
Leaf of N. 
tabacum 
(Tso and 
Jeffrey, 
1953) 
Myosmine 442649 
 
Leaf of N. 
tabacum 
(Tso and 
Jeffrey, 
1953) 
3-acetylpyridine 9589 
 
Leaf of N. 
tabacum 
(Tso and 
Jeffrey, 
1953) 
2, 3′-dipyridyl 11389 
 
Leaf of N. 
tabacum 
(Tso and 
Jeffrey, 
1953) 
Nicotinamide 936 
 
Leaf of N. 
tabacum 
(Tso and 
Jeffrey, 
1953) 
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Name CID* Structure Material References 
Nicotinic acid 938 
 
Leaf of N. 
tabacum 
(Tso and 
Jeffrey, 
1953) 
Anatalline 443848 
 
Root of N. 
tabacum 
(Kisaki et al., 
1968) 
5-methyl-2,3′-
bipyridine  
15543761 
 
Leaf of N. 
tabacum 
(Warfield et 
al., 1972) 
N′-formylnornicotine 528369 
 
Leaf of N. 
tabacum 
(Warfield et 
al., 1972) 
N′- acetylnornicotine 165384 
 
Leaf of N. 
tabacum 
(Warfield et 
al., 1972) 
3,5-bis-(1-methyl-
pyrrolidin-2-yl)-
pyridine  
 
 
Root of N. 
tabacum 
(Wei et al., 
2005) 
2,4′-dipyridyl 68488 
 
Leaf of N. 
tabacum 
(Nyiredy et 
al., 1986) 
4,4′-dipyridyl 11107 
 
Leaf of N. 
tabacum 
(Nyiredy et 
al., 1986) 
N′-methylanabasine 29758 
 
Leaf of N. 
tabacum 
(Matsush et 
al., 1983) 
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Name CID* Structure Material References 
N′-methylanatabine 3904269 
 
Leaf of N. 
tabacum 
(Matsush et 
al., 1983) 
Cotinine 408 
 
Leaf of N. 
tabacum 
(Matsush et 
al., 1983) 
N′-formylanabasine 55250656 
 
Leaf of N. 
tabacum 
(Matsush et 
al., 1983) 
N′-formylanatabine 528365 
 
Leaf of N. 
tabacum 
(Matsush et 
al., 1983) 
N′-
hexanoylnornicotine 
528370 
 
Leaf of N. 
tabacum 
(Matsush et 
al., 1983) 
N′-
octanoylnornicotine 
162334 
 
Leaf of N. 
tabacum 
(Matsush et 
al., 1983) 
1′-(6-
hydroxyoctanonyl) 
nornicotine 
 
 
Leaf of N. 
tabacum 
(Matsush et 
al., 1983) 
1′-(7-
hydroxyoctanonyl) 
nornicotine 
 
 
Leaf of N. 
tabacum 
(Matsush et 
al., 1983) 
Nicotyrine 10249 
 
Leaf of N. 
tabacum 
(Matsush et 
al., 1983) 
N′-nitrosonornicotine 27919 
 
Leaf of N. 
tabacum 
(Andersen et 
al., 1989) 
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Name CID* Structure Material References 
N′-nitrosoanatabine 528366 
 
Leaf of N. 
tabacum 
(Andersen et 
al., 1989) 
N′-acetylanatabine 528364 
 
Leaf of N. 
tabacum 
(Andersen et 
al., 1989) 
4-(N-methyl-N-
nitrosamino)-1-(3-
pyridyl)butanone 
47289 
 
Leaf of N. 
tabacum 
(Andersen et 
al., 1989) 
N′-
butanoylnornicotine 
528368 
 
Leaf of N. 
tabacum 
(Andersen et 
al., 1989) 
N′-
carboethoxynornicoti
ne 
2777155 
 
Cell culture 
of N. 
plumbaginifol
ia 
(Bartholome
usz et al., 
2005a) 
N′-nitrosoanabasine 14335 
 
Leaf of N. 
rustica and N. 
tabacum 
(Bhide et al., 
1987) 
N′-ethylnornicotine 4658388 
 
Leaf of N. 
tabacum 
(Braumann et 
al., 1990) 
N′-
isopropylnornicotine 
21355371 
 
Leaf of N. 
tabacum 
(Leete, 1981) 
Anabaseine 18985 
 
Leaf of N. 
tabacum 
(Kisaki and 
Tamaki, 
1966) 
* PubChem compound number  ―http://pubchem.ncbi.nlm.nih.gov/‖  
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Table S1.2. N′-dealkylation in Nicotiana species, based on feeding assays. 
Substrate Structure Material Reference 
(R,S)-nicotine 
 
Excised leaf of N. 
glutinosa[1] and N. 
tabacum[2], N. 
plumbaginifolia cell 
culture [3] 
[1] (Dawson, 
1951); [2] 
(Kisaki et al., 
1978); [3] 
(Mesnard et al., 
2001)  
(R,S)-N-
ethylnornicotine 
 
Excised leaf of N. 
glutinosa 
(Dawson, 1951) 
2-(1-benzyl-
pyrrolidin-3-yl)-
pyridine  
Excised leaf of N. 
tabacum  
(Kisaki et al., 
1978) 
(R,S)-1-methyl-2-
phenylpyrrolidine* 
 
N. plumbaginifolia cell 
culture 
(Bartholomeusz 
et al., 2005b; 
Robins et al., 
2007) 
2-(3-fluorophenyl)-1-
methylpyrrolidine 
 
N. plumbaginifolia cell 
culture 
(Robins et al., 
2007) 
1-methyl-2-(3-
(trifluoromethyl)phen
yl)pyrrolidine 
 
N. plumbaginifolia cell 
culture 
(Robins et al., 
2007) 
6-Hydroxynicotine 
 
Excised leaf of N. 
tabacum 
(Kisaki et al., 
1978) 
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Substrate Structure Material Reference 
(R,S)-N-
methylanabasine 
 
N. plumbaginifolia cell 
culture [1]; excised leaf 
of N. glutinosa [2] 
[1] 
(Bartholomeusz 
et al., 2005b); [2] 
(Dawson, 1951) 
(R,S)-N-
ethylanabasine 
 
Excised leaf of N. 
glutinosa 
 (Dawson, 1951) 
(R,S)-N-
methylanatabine 
 
N. plumbaginifolia cell 
culture 
(Bartholomeusz 
et al., 2005b) 
N-ethyl-N-methyl-2-
pyridin-3-yl-
ethanamine  
Excised leaf of N. 
tabacum 
(Kisaki et al., 
1978) 
N,N-dimethyl-1-
(pyridin-3-
yl)methanamine 
 
Excised leaf of N. 
tabacum 
(Kisaki et al., 
1978) 
N,N-diethyl-1-
(pyridin-3-
yl)methanamine  
Excised leaf of N. 
tabacum 
(Kisaki et al., 
1978) 
*no product isolated in excised leaf (Kisaki et al., 1978). 
 Compounds with dashed border are found in tobacco. 
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Table S1.3. Compounds not N′-demethylated by excised leaves of N. tabacum (Kisaki 
et al., 1978). 
Substrate Structure  Substrate Structure 
Nicotyrine 
 
 1-methyl-2-
(naphthalen-2-
yl)pyrrolidine 
 
Cotinine 
 
 Dioxynicotine 
(102738) 
 
2-methyl-6-pyridin-3-
yloxazinane (85906) 
 
 Nicotine N-oxide 
(17785) 
 
Dihydrometanicotine 
 
 N′-
acetylnornicotiine 
 
pseudooxynicotine 
 
 1,2-
dimethylpiperidine 
 
4-(methylamino)-1-
(pyridin-3-yl)butan-1-
ol  
 N-(pyridin-3-
ylmethyl)ethanami
ne (4716480)  
N-methyl-4-(pyridin-
3-yl)but-3-en-1-amine 
 
 N-methyl-N-
propylnicotinamid
e  
N,N-dimethyl-4-
(pyridin-3-yl)butan-1-
amine  
 N′-
acetylnornicotine 
(528367)  
2-Hydroxynicotine 
 
 (R,S)-1-methyl-2-
phenylpyrrolidine 
 
Note: Dashed border represent the present in tobacco.  
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Table S2.1. Alkaloids concentrations in different tissues of four tobacco lines. Data 
are average of four plants, and the numbers in parenthesis are standard deviation. 
Treatment 
Nic Nnic Anab Anat Dem 
mg g
-1
  mg g
-1
 mg g
-1
  mg g
-1
 % 
DH98-325-6 Top lamina 37.0 (6.7) 0.29 (0.10) 0.14 (0.03) 1.96 (0.33) 0.8 (0.1) 
RNAi #2-8 Stalk 5.6 (0.5) 0.02 (0.01) 0.00 (0.01) 0.17 (0.02) 0.3 (0.1) 
 Bottom lamina 41.3 (5.6) 0.33 (0.07) 0.15 (0.02) 2.20 (0.33) 0.8 (0.1) 
 Root 7.9 (0.4) 0.06 (0.01) 0.04 (0.01) 0.28 (0.01) 0.7 (0.0) 
       
L8 Top lamina 40.7 (7.2) 1.23 (0.23) 0.15 (0.03) 1.65 (0.27) 2.9 (0.1) 
 Stalk 4.8 (1.8) 0.14 (0.03) 0.00 (0.01) 0.15 (0.04) 3.2 (1.4) 
 Bottom lamina 47.2 (5.3) 1.48 (0.16) 0.16 (0.02) 1.84 (0.17) 3.1 (0.4) 
 Root 6.7 (1.3) 0.25 (0.09) 0.05 (0.01) 0.34 (0.11) 3.5 (0.7) 
        
TN90LC Top lamina 35.5 (6.1) 1.11 (0.28) 0.13 (0.01) 1.82 (0.51) 3.0 (0.2) 
 Stalk 7.2 (0.2) 0.16 (0.00) 0.02 (0.00) 0.25 (0.12) 2.2 (0.0) 
 Bottom lamina 39.4 (6.8) 1.44 (0.44) 0.16 (0.01) 2.11 (0.28) 3.5 (0.5) 
 Root 6.8 (1.2) 0.20 (0.04) 0.04 (0.00) 0.26 (0.00) 2.9 (0.0) 
        
RM52 Top lamina 33.1 (3.1) 1.75 (0.15) 0.14 (0.01) 1.42 (0.16) 5.0 (0.2) 
 Stalk 5.7 (0.7) 0.15 (0.03) 0.00 (0.01) 0.21 (0.05) 2.5 (0.2) 
 Bottom lamina 24.1 (1.6) 9.92 (2.01) 0.15 (0.01) 2.37 (0.29) 29.1 (5.3) 
 Root 7.8 (1.9) 0.44 (0.11) 0.07 (0.02) 0.59 (0.15) 5.3 (0.4) 
Note: Nic: nicotine; Nnic: nornicotine; Anab: anabasine; Anat: anatabine; Dem: 
Demethylation. 
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Table S2.2. Alkaloids concentrations in ethephon-treated tobacco. Data are average 
of two replicates. 
Treatment Nic Nnic Anab Anat Dem 
   mg g
-1
  mg g
-1
 mg g
-1
  mg g
-1
 % 
Freeze-dried 
leaf 
DH98-325-6 RNAi#2-8 28.9 0.18 0.10 1.17 0.7 
DH98-325-5 17.2 0.50 0.06 0.78 2.9 
DH98-325-6 22.6 1.24 0.09 0.93 5.2 
              
Ethylene-
treated leaf 
DH98-325-6 RNAi#2-8 36.1 0.22 0.13 1.47 0.6 
DH98-325-5 19.0 0.92 0.07 0.84 6.0 
DH98-325-6 11.7 13.90 0.10 1.08 54.3 
              
Root 
DH98-325-6 RNAi#2-8 5.2 0.08 0.05 0.39 1.5 
DH98-325-5 6.6 0.22 0.07 0.68 3.4 
DH98-325-6 5.4 0.31 0.08 0.52 5.3 
Note: Nic: nicotine; Nnic: nornicotine; Anab: anabasine; Anat: anatabine; Dem: 
Demethylation. 
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Table S2.3. Alkaloids concentrations in e4 mutants. Data are single replicate. 
Treatment Mutation 
Nic Nnic Anab Anat Dem 
mg g
-1
  mg g
-1
 mg g
-1
  mg g
-1
 % 
TN90LC  32.1 1.10 0.17 1.38 3.4 
DH98-325-6 (parent, P)  9.3 22.77 0.17 1.51 71.2 
       
e4 #1 G986A 22.8 0.70 0.10 0.81 3.1 
e4 #2 C1372T 22.7 0.90 0.13 0.97 4.0 
e4 #3 G1375A 26.9 1.12 0.18 1.63 4.1 
e4 #4 G1092T 21.1 1.19 0.15 0.91 5.2 
e4 #4x P; F1  19.1 5.97 0.14 1.06 23.7 
e4 #5 G886A 23.1 7.84 0.12 1.29 25.2 
e4 #1x P; F1  16.3 8.22 0.12 1.03 32.9 
e4 #2x P; F1  17.1 9.54 0.10 0.84 38.7 
e4 #3x P; F1  19.0 14.35 0.20 1.81 43.8 
e4 #6 C1280T 8.5 20.55 0.14 1.32 70.7 
e4 #7 G601A 9.8 25.90 0.16 1.28 72.5 
e4 #8 C113T 5.0 17.56 0.14 1.37 77.5 
e4 #9 G511A 3.9 22.82 0.12 1.10 85.8 
Note: Nic: nicotine; Nnic: nornicotine; Anab: anabasine; Anat: anatabine; Dem: 
Demethylation. 
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Table S2.4. Alkaloids concentrations in RNAi plants. Data are single replicate. 
Treatment Nic Nnic Anab Anat Dem 
 mg g
-1
  mg g
-1
 mg g
-1
  mg g
-1
 % 
TN90H (high converter) 6.7 26.33 0.21 1.92 79.8 
TN90L (low converter) 31.4 0.81 0.13 0.99 2.5 
L8L (low converter) 39.7 1.10 0.21 1.48 2.7 
      
DH98-325-5 (Non-Converter)  41.8 0.90 0.17 1.31 2.1 
DH98-325-5 RNAi #1-1 41.3 1.19 0.19 1.42 2.8 
DH98-325-5 RNAi #2-1 50.3 0.33 0.23 1.55 0.6 
DH98-325-5 RNAi #1-2 40.7 0.31 0.17 1.31 0.8 
DH98-325-5 RNAi #3-1 40.5 0.38 0.21 1.42 0.9 
DH98-325-5 RNAi #1-3 37.4 0.31 0.16 1.20 0.8 
DH98-325-5 RNAi #1-4 48.9 0.42 0.27 1.79 0.8 
DH98-325-5 RNAi #1-5 41.6 2.44 0.19 1.44 5.5 
      
DH98-325-6 (Converter) 8.8 39.80 0.27 2.31 81.9 
DH98-325-6 RNAi #1-1 24.8 11.00 0.21 1.66 30.7 
DH98-325-6 RNAi #2-1 29.2 4.33 0.17 1.25 12.9 
DH98-325-6 RNAi #2-2 35.6 2.97 0.16 1.10 7.7 
DH98-325-6 RNAi #1-2 42.4 0.46 0.19 1.47 1.1 
DH98-325-6 RNAi #2-3 30.7 3.31 0.14 0.89 9.7 
DH98-325-6 RNAi #1-3 46.7 0.33 0.20 1.50 0.7 
DH98-325-6 RNAi #2-4 43.8 0.49 0.20 1.39 1.1 
DH98-325-6 RNAi #2-5 39.9 2.45 0.19 1.35 5.8 
DH98-325-6 RNAi #2-6 37.2 0.34 0.18 1.19 0.9 
DH98-325-6 RNAi #2-7 39.2 0.75 0.18 1.22 1.9 
DH98-325-6 RNAi #2-8 45.1 0.44 0.21 1.41 1.0 
DH98-325-6 RNAi #2-9 44.0 1.55 0.21 1.45 3.4 
DH98-325-6 RNAi #3-1 33.4 0.71 0.16 1.17 2.1 
DH98-325-6 RNAi #3-2 33.8 0.60 0.18 1.22 1.7 
Note: Nic: nicotine; Nnic: nornicotine; Anab: anabasine; Anat: anatabine; Dem: 
Demethylation. 
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Table S3.1. Comparison of Michaelis-Menten constants with literatures. 
  This study Report 
References 
  R S RS 
CYP82E4 Km  1.90 ± 0.36 2.76 ± 0.65 3.9* (Xu et al., 2007a) 
 Vmax 0.55 ± 0.02 0.17 ± 0.01 0.54*  
      
CYP82E5v2 Km 3.02 ± 1.27 2.3 ± 2.37 5.6 ± 1.4 (Gavilano and 
Siminszky, 2007)  Vmax 0.04 ± 0.004 0.003 ± 0.0007 0.7 ± 0.02 
      
CYP82E10 Km 0.78 ± 0.24 3.70 ± 5.22 3.9 (Lewis et al., 
2010)  Vmax 0.12 ± 0.01 0.001 ± 0.002  
Note: Units for Km: µM; units for Vmax: nmol min
-1
 mg
-1
 protein.  
        *Results are from leaf microsome of high expressed CYP82E4. 
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Table S3.2. Evolution of nicotine demethylases in N. tabacum L. 
Demethylase Originality Function References 
CYP82E2 N. sylvestris Inactive, E375K and 
W422 mutations 
(Chakrabarti et al., 
2007) 
CYP82E3 N. tomentosiformis Inactive, W330C (Gavilano et al., 
2007) 
CYP82E4 N. tomentosiformis Active, Unstable 
mutation 
(Gavilano et al., 
2007) 
CYP82E5v2 N. tomentosiformis Active (Gavilano and 
Siminszky, 2007) 
CYP82E10 N. sylvestris Active (Lewis et al., 2010) 
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Table S4.1. Alkaloid concentrations of mutant cured leaf lamina from 2010 field 
trial. Data are average of three replicates, and the numbers in parenthesis are standard 
deviation. 
Treatment Nic Nnic Anab Anat Dem 
mg g
-1
  mg g
-1
 mg g
-1
  mg g
-1
 % 
Parent 16.2 (3.5) 24.80 (2.28) 0.22 (0.01) 1.67 (0.10) 60.8 (3.2) 
e4E5E10 29.7 (7.7) 0.88 (0.22) 0.13 (0.03) 1.00 (0.18) 2.9 (0.1) 
E4e5E10 11.5 (1.7) 20.86 (2.35) 0.18 (0.01) 1.46 (0.13) 64.4 (5.6) 
E4E5e10 15.0 (2.1) 19.30 (4.00) 0.15 (0.03) 1.35 (0.48) 56.0 (1.6) 
e4e5E10 31.7 (2.5) 0.90 (0.11) 0.18 (0.03) 1.57 (0.23) 2.7 (0.1) 
e4E5e10 37.6 (3.8) 0.95 (0.11) 0.15 (0.03) 1.22 (0.31) 2.5 (0.0) 
E4e5e10 14.0 (0.5) 18.34 (1.95) 0.15 (0.01) 0.89 (0.13) 56.6 (3.5) 
e4e5e10 44.2 (1.2) 0.48 (0.04) 0.17 (0.01) 1.32 (0.26) 1.1 (0.1) 
Note: Nic: nicotine; Nnic: nornicotine; Anab: anabasine; Anat: anatabine; Dem: 
Demethylation. 
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Table S4.2. Nitrite and nitrate levels in mutant cured leaf lamina from 2011 field 
trial. Data are average of four replicates, and the numbers in parenthesis are standard 
deviation. 
Treatment 
[NO2
-
]N [NO3
-
]N Total N 
µg/g µg/g % 
TN90LC 2.7 (0.6) 878  (250) 4.0 (0.1) 
Parent 2.4 (0.2) 1182  (748) 4.0 (0.3) 
e4E5E10 3.0 (0.6) 3389(1243) 4.5 (0.2) 
E4e5E10 2.8 (0.4) 2075  (956) 4.5 (0.2) 
E4E5e10 2.6 (0.2) 1510  (335) 4.7 (0.3) 
e4e5E10 2.8 (0.4) 1002  (725) 4.1 (0.6) 
e4E5e10 3.6 (0.9) 2617  (826) 4.7 (0.5) 
E4e5e10 2.7 (0.3) 1755  (581) 4.6 (0.3) 
e4e5e10 2.9 (0.1) 2679(1090) 4.6 (0.1) 
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Table S4.3. Alkaloids concentration of self-grafted mutant tissues. Data are average 
of three replicates, and the numbers in parenthesis are standard deviation.  
Treatment 
Nic Nnic Anab Anat Dem 
mg g
-1
  mg g
-1
 mg g
-1
  mg g
-1
 % 
Green 
leaf 
lamina 
E4E5E10 12.1 (5.2) 4.25 (0.85) 0.03 (0.00) 0.67 (0.25) 28.4(13.6) 
e4e5E10 28.0(17.0) 0.48 (0.29) 0.05 (0.03) 1.11 (0.42) 1.7 (0.1) 
e4E5e10 18.8 (5.3) 0.36 (0.08) 0.02 (0.00) 0.44 (0.07) 1.9 (0.1) 
E4e5e10 19.8 (2.1) 2.39 (1.32) 0.03 (0.00) 0.48 (0.07) 10.8 (6.3) 
e4e5e10 18.9 (9.8) 0.08 (0.04) 0.02 (0.01) 0.26 (0.17) 0.4 (0.0) 
  
     
Ethephon 
treated 
leaf 
lamina 
E4E5E10 0.5 (0.4) 17.68 (5.03) 0.04 (0.01) 0.98 (0.42) 97.8 (1.7) 
e4e5E10 42.2 (8.9) 0.85 (0.08) 0.08 (0.01) 1.75 (0.22) 2.0 (0.4) 
e4E5e10 27.2 (8.4) 0.64 (0.18) 0.03 (0.01) 0.67 (0.15) 2.3 (0.1) 
E4e5e10 2.0 (2.0) 20.38 (5.77) 0.04 (0.01) 0.70 (0.21) 90.3(10.7) 
e4e5e10 25.7(11.7) 0.26 (0.03) 0.02 (0.02) 0.37 (0.22) 1.1 (0.4) 
  
     
Root 
E4E5E10 3.6 (0.2) 0.20 (0.07) 0.03 (0.01) 0.35 (0.03) 5.3 (1.6) 
e4e5E10 5.0 (2.5) 0.11 (0.04) 0.03 (0.02) 0.48 (0.32) 2.2 (0.3) 
e4E5e10 4.7 (1.8) 0.18 (0.10) 0.02 (0.01) 0.23 (0.06) 3.6 (0.7) 
E4e5e10 4.2 (0.5) 0.20 (0.06) 0.02 (0.01) 0.21 (0.01) 4.6 (1.8) 
e4e5e10 5.1 (0.0) 0.03 (0.00) 0.02 (0.00) 0.17 (0.06) 0.7 (0.1) 
Note: Nic: nicotine; Nnic: nornicotine; Anab: anabasine; Anat: anatabine; Dem: 
Demethylation. 
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Table S4.4. Alkaloids concentration of tomato(scion)/ mutant(root) grafts tissues. 
Data are average of three replicates, and the numbers in parenthesis are standard 
deviation. 
Treatment 
Nic Nnic Anab Anat Dem 
mg g
-1
  mg g
-1
 mg g
-1
  mg g
-1
 % 
Green 
leaf 
lamina 
Tom/E4E5E10 18.2 (5.1) 0.40 (0.09) 0.02 (0.00) 0.44 (0.08) 2.2 (0.2) 
Tom/e4e5E10 10.1 (1.4) 0.23 (0.02) 0.02 (0.00) 0.44 (0.06) 2.3 (0.2) 
Tom/e4E5e10 12.8 (3.5) 0.26 (0.11) 0.01 (0.01) 0.30 (0.01) 1.9 (0.4) 
Tom/E4e5e10 19.1 (7.3) 0.27 (0.07) 0.01 (0.01) 0.18 (0.08) 1.4 (0.3) 
Tom/e4e5e10 16.0(11.1) 0.20 (0.09) 0.01 (0.01) 0.17 (0.11) 1.4 (0.5) 
  
     
Root 
Tom/E4E5E10 4.0 (0.4) 0.34 (0.08) 0.02 (0.00) 0.33 (0.05) 7.7 (1.1) 
Tom/e4e5E10 4.3 (0.8) 0.09 (0.02) 0.02 (0.00) 0.43 (0.09) 2.1 (0.2) 
Tom/e4E5e10 3.2 (0.3) 0.19 (0.05) 0.01 (0.00) 0.15 (0.01) 5.5 (1.0) 
Tom/E4e5e10 3.9 (0.4) 0.11 (0.02) 0.02 (0.01) 0.19 (0.10) 2.7 (0.5) 
Tom/e4e5e10 2.8 (1.0) 0.02 (0.01) 0.01 (0.01) 0.12 (0.05) 0.7 (0.2) 
Note: Nic: nicotine; Nnic: nornicotine; Anab: anabasine; Anat: anatabine; Dem: 
Demethylation. 
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Table S4.5. Alkaloids concentration of mutant (scion)/ triple mutant (root) grafts 
tissues. Data are average of two replicates, and the numbers in parenthesis are standard 
deviation. 
Treatment 
Nic Nnic Anab Anat Dem 
mg g
-1
  mg g
-1
 mg g
-1
  mg g
-1
 % 
Green 
leaf 
lamina 
E4E5E10/e4e5e10 19.2 (6.6) 3.28 (2.21) 0.03 (0.00) 0.50 (0.00) 13.7 (4.5) 
e4e5E10/e4e5e10 27.5 (4.5) 0.58 (0.07) 0.03 (0.00) 0.55 (0.06) 2.1 (0.1) 
e4E5e10/e4e5e10 21.6(11.5) 0.48 (0.19) 0.02 (0.01) 0.38 (0.20) 2.3 (0.4) 
E4e5e10/e4e5e10 21.0 (4.8) 3.67 (0.60) 0.03 (0.01) 0.43 (0.15) 15.0 (0.9) 
  
     Ethephon 
treated 
leaf 
lamina 
E4E5E10/e4e5e10 1.3 (1.3) 20.20 (8.03) 0.05 (0.01) 0.71 (0.03) 94.9 (3.6) 
e4e5E10/e4e5e10 33.6 (4.7) 0.84 (0.08) 0.04 (0.00) 0.67 (0.02) 2.5 (0.6) 
e4E5e10/e4e5e10 26.2(13.0) 0.57 (0.18) 0.03 (0.02) 0.48 (0.27) 2.2 (0.5) 
E4e5e10/e4e5e10 4.7 (0.6) 22.38 (2.44) 0.04 (0.01) 0.61 (0.15) 82.7 (0.4) 
  
     
Root 
E4E5E10/e4e5e10 4.5 (2.5) 0.03 (0.02) 0.04 (0.02) 0.32 (0.11) 0.7 (0.1) 
e4e5E10/e4e5e10 5.2 (0.6) 0.03 (0.00) 0.02 (0.00) 0.23 (0.04) 0.6 (0.0) 
e4E5e10/e4e5e10 4.1 (0.8) 0.02 (0.00) 0.01 (0.00) 0.16 (0.02) 0.6 (0.1) 
E4e5e10/e4e5e10 4.5 (1.9) 0.03 (0.01) 0.03 (0.01) 0.21 (0.06) 0.7 (0.1) 
Note: Nic: nicotine; Nnic: nornicotine; Anab: anabasine; Anat: anatabine; Dem: 
Demethylation. 
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Figure S1.1. Nicotine degradation in bacteria and fungi. Arthrobacter nicotinovorans 
(Brandsch, 2006),Peudomonas putida S16 (Tang et al., 2009), Pseudomonas sp CS3 
(Wang et al., 2012), Aspergillus oryzae 112822 (Meng et al., 2010). Enzymes listed: 
NDH: nicotine dehydrogenase; 6HLNO and 6HDNO: 6-hydroxy-L- and 6-hydroxy-D-
nicotine oxidases; KDH: ketone dehydrogenase; DHPONH: 2, 6-
dihydroxypseudooxynicotine hydrolase. Compounds in bracket were postulated by 
referring to published reports. 
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Figure S1.2. Nicotine degradation in human based on urinary metabolites 
(Hukkanen et al., 2005). Enzymes listed: CYP: cytochrome P450 enzymes; AO: aldehyde 
oxidase; FMO: Flavin-containing monooxygenase; AMT: amine N-methyltransferase; 
UGT: UDP-glucuronosyltransferase. Detailed primary routes of CYP catalyzed nicotine 
metabolism can be found in previous papers (Dicke et al., 2005; Pogocki et al., 2007)  
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Figure S1.3. Alignment of the CYP82E4, CYP82E5 and CYP82E10 predicted 
protein sequences. Domains predicted to be involved in substrate recognition are boxed. 
Sequences that are highly conserved in a diversity of plant P450 enzymes are underlined 
(Xu et al., 2007a).  
 
  
                 1                                                                                                100 
  CYP82E4    (1) MLSPIEAIVGLVTFTFLFFFLWTKKSQKPSKPLPPKIPGGWPVIGHLFHFNDDGDDRPLARKLGDLADKYGPVFTFRLGLPLVLVVSSYEAVKDCFSTND 
  CYP82E5    (1) MVSPVEAIVGLVTLTLLFYFLWPKKFQIPSKPLPPKIPGGWPVIGHLFYFDDDGDDRPLARKLGDLADKYGPVFTFRLGLPLVLIVSSYEAVKDCFSTND 
 CYP82E10    (1) MVSPVEAIVGLVTLTLLFYFIRTKKSQKPSKPLPPKIPGGWPVIGHLFYFDDDSDDRPLARKLGDLADKYGPVFTFRLGLPLVLVVSSYEAIKDCFSTND 
 
                 101                                                                                              200 
  CYP82E4  (101) AIFSNRPAFLYGDYLGYNNAMLFLANYGPYWRKNRKLVIQEVLSASRLEKFKHVRFARIQASIKNLYTRIDGNSSTINLTDWLEELNFGLIVKMIAGKNY 
  CYP82E5  (101) AIFSNRPAFLYGEYLGYNNAMLFLTKYGPYWRKNRKLVIQEVLSASRLEKLKHVRFGKIQTSIKSLYTRIDGNSSTINLTDWLEELNFGLIVKMIAGKNY 
 CYP82E10  (101) AIFSNRPAFLYGEYLGYNNAMLFLTKYGPYWRKNRKLVIQEVLCASRLEKLKHVRFGEIQTSIKNLYTRIDGNSSTINLTDWLEELNFGLIVKMIAGKNY 
 
                 201                                                                                              300 
  CYP82E4  (201) ESGKGDEQVERFKKAFKDFMILSMEFVLWDAFPIPLFKWVDFQGHVKAMKRTFKDIDSVFQNWLEEHINKREKMEVNAEGNEQDFIDVVLSKMSNEYLGE 
  CYP82E5  (201) ESGKGDEQVERFRKAYKDFIILSMEFVLWDAFPIPLFKWVDFQGYVKAMKRTFKDIDSVFQNWLEEHVKKREKMEVNAQGNEQDFIDVVLSKMSNEYLDE 
 CYP82E10  (201) ESGKGDEQVERFRKAFKDFIILSMEFVLWDAFPIPLFKWVDFQGHVKAMKRTFKDIDSVFQNWLEEHVKKKEKMEVNAEGNEQDFIDVVLSKMSNEYLDE 
 
                 301                                                                                              400 
  CYP82E4  (301) GYSRDTVIKATVFSLVLDAADTVALHINWGMALLINNQKALTKAQEEIDTKVGKDRWVEESDIKDLVYLQAIVKEVLRLYPPGPLLVPHENVEDCVVSGY 
  CYP82E5  (301) GYSRDTVIKATVFSLVLDAADTVALHMNWGMALLINNQHALKKAQEEIDKKVGKERWVEESDIKDLVYLQAIVKEVLRLYPPGPLLVPHENVEDCVVSGY 
 CYP82E10  (301) GYSRDTVIKATVFSLVLDAADTVALHMNWGMALLINNQHALKKAQEEIDKKVGKDRWVEESDIKDLVYLQTIVKEVLRLYPPGPLLVPHENVEDCVVSGY 
 
                 401                                                                                              500 
  CYP82E4  (401) HIPKGTRLFANVMKLQRDPKLWSDPDTFDPERFIATDIDFRGQYYKYIPFGSGRRSCPGMTYALQVEHLTMAHLIQGFNYRTPNDEPLDMKEGAGITIRK 
  CYP82E5  (401) HIPKGTRLFANVMKLQRDPKLWSNPDKFDPERFFADDIDYRGQHYEFIPFGSGRRSCPGMTYALQVEHLTIAHLIQGFNYKTPNDEPLDMKEGAGLTIRK 
 CYP82E10  (401) HIPKGTRLFANVMKLQRDPKLWSNPDKFDPERFFAADIDFRGQHYEFIPFGSGRRSCPGMTYAMQVEHLTIAHLIQGFNYKTPNDEPLDMKEGAGLTIRK 
 
                 501           517 
  CYP82E4  (501) VNPVELIIAPRLAPELY 
  CYP82E5  (501) VNPVEVTITARLAPELY 
 CYP82E10  (501) VNPIEVVITPRLTPELY 
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Figure S3.1. Competitive inhibition of CYP82E4-catalyzed (S)-nicotine 
demethylation by (R)-nicotine shown in Lineweaver-Burk plot. R
2
 for all four fitted 
lines are over 0.97.  
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Figure S3.2. Inability of CYP82E4 to generate leaf nornicotine enantiomeric 
composition in vitro. (A) CYP82E4 produces stable EFnnic from varying concentration of 
nicotine substrate (0.03 EFnic).  (B) EFnnic produced from different nicotine enantiomeric 
compositions by recombinant CYP82E4 in vitro. Data points in (A) are the average of 
three independent assays, and the bars represent the standard deviation. In (B), the 
nicotine mixtures were prepared with 0.2 µM, 2 µM and 6 µM of (R)-nicotine in 
combination with 0.3 µM, 1 µM,  3 µM, 9 µM and 30 µM of (S)-nicotine to cover the 
substrate range. The results were fit into Exponential Rise to Maximum Equation by 
Sigmaplot 12.    
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Figure S3.3. Time course of the demethylation of 10 µM nicotine (0.03 EFnic) 
incubated with CYP82E4, CYP82E5v2 or CYP82E10 separately, or all together as 
measured as demethylation (A) or nornicotine composition (B). For collective 
incubation, same amount of E5 and E10 were mixed and incubated with substrate, and at 
30 min equal amount of E4 was added into mixture for incubation. Total protein in single 
and collective enzyme incubation are same. Each data are average of two independent 
assays. 
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Figure S3.4. Anabasine was identified in the incubations of methylanabasine with 
CYP82E4, CYP82E5v2 and CYP82E10 in vitro. Microsomes were isolated from yeast 
not expressing any introduced P450s or the indicated tobacco genes, and incubated with 
methylanabasine. The reaction mixtures were extracted and analyzed by GC-MS. (A) 
Extracted GC-MS chromatographs of incubations of methylanabasine with CYP82E4, 
CYP82E5v2 and CYP82E10 in vitro. Peak 1: quinoline (internal standard); peak 2: 
methylanabasine; peak 3: anabasine. (B) The identity of anabasine (peak 3) is confirmed 
by mass spectrum.  
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Figure S3.5. Nicotine demethylation inhibited by methylanabasine and N'-
ethylnornicotine catalyzed by CYP82E4, CYP82E5v2 and CYP82E10. 10 µM 
racemic nicotine was incubated with CYP82E4, CYP82E5v2 and CYP82E10, 
respectively, and 2.5 µM, 5 µM and 10 µM of methylanabasine or ethylnornicotine was 
added to the reaction mixture. Each bar is the average of two independent assays.  
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Figure S3.6. Two possible mechanisms in N-demethylation of nicotine catalyzed by 
cytochrome P450 enzymes (Meunier et al., 2004): hydrogen atom transfer (HAT) 
versus single electron transfer (SET). Presumably (R)-nicotine is demethylated into 
(R)-nornicotine, and (S)-nicotine is converted into (S)-nornicotine. Note the hydrogen 
atom at the 2'-C position is not involved in either mechanism.                                                                                                                                                                      
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Figure S3.7. Racemic nicotine separation by chiral HPLC. Retention time for (S)-
nicotine was 7.45 min and for (R)-nicotine was 8.31 min. Nornicotine was chemically 
methylated back to nicotine and separated by this method.   
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Figure S4.1. TSNAs level of mutants grown in the field in 2010 and 2011. 1: TN90LC 
(2011 data only); 2: Parent; 3: e4E5E10; 4: E4e5E10; 5: E4E5e10; 6: e4e5E10; 7: 
e4E5e10; 8: E4e5e10; 9: e4e5e10. Each data is the average of three (2010) or four (2011) 
replicates. The error bars represent standard deviation. The error bars represent standard 
deviation. 
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Figure S4.2. Possible reason for the increase of (R)-nornicotine in tobacco with 
active CYP82E4 during the first two weeks of curing. (A) (R)-nornicotine derivatives 
could be the source of (R)-nornicotine during first two weeks of curing. (B) Total (R) 
enantiomer percentage changes of nicotine plus nornicotine in nicotine demethylase 
mutants throughout growth and curing. Each data point is average of four bulk samples, 
and each bulk sample is a mixture of five middle leaves from five plants. The error bars 
represent standard deviation. +/- below the bars indicate the presence/absence of a 
functional demethylase gene. 
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Figure S4.3. Selection of EMS-induced mutants in nicotine demethylase genes 
(Lewis et al., 2010). Mutants used in this study are highlighted in yellow. The particular 
amino acid mutation in each of non-functional demethylases (amino acid position 
substitution), and the zygosity at each locus noted (e4e4 – homozygous knock-out 
mutation) are also indicated. 
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Figure S4.4. Production cycle of tobacco in 2011. Red dots represent sampling time. 
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Figure S4.5. Temperature and relative humidity during curing. Cut tobacco plants 
were hung on a wagon in the air-curing barn. Tobacco plants were sampled at 0d 
(harvest), 14d and 72d (cured).  
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